178 results on '"Fractures, Spontaneous etiology"'
Search Results
2. Are Pathologic Fractures in Patients With Osteosarcoma Associated With Worse Survival Outcomes? A Systematic Review and Meta-analysis.
- Author
-
Gonzalez MR, Bedi A, Karczewski D, and Lozano-Calderon SA
- Subjects
- Humans, Amputation, Surgical, Limb Salvage methods, Fractures, Spontaneous etiology, Fractures, Spontaneous surgery, Osteosarcoma pathology, Bone Neoplasms complications, Bone Neoplasms surgery, Bone Neoplasms drug therapy
- Abstract
Background: Pathologic fractures occur in 5% to 10% of patients with osteosarcoma, and prior studies have suggested they are prognostically important. However, because they represent an uncommon event in the setting of an already rare disease, most studies fail to reach conclusive findings, and there is no agreement about how best to treat pathologic fractures., Questions/purposes: (1) Is the occurrence of a pathologic fracture in patients with osteosarcoma associated with poorer overall survivorship? (2) Is the occurrence of a pathologic fracture in patients with osteosarcoma associated with poorer local recurrence-free survival or metastasis-free survival? (3) Is the surgical approach (amputation or limb salvage) associated with differences in local recurrence rates in patients with osteosarcoma with pathologic fractures?, Methods: This systematic review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Our study was registered in PROSPERO (ID: 380459). A search of the PubMed and Embase databases resulted in 625 and 747 titles, respectively. After application of the inclusion and exclusion criteria, 21 articles were finally included. Quality assessment of all studies was performed using the Newcastle-Ottawa Quality Assessment Scale. The Risk of Bias In Non-Randomized Studies of Interventions tool was used in the 11 articles that evaluated the effect of an intervention (amputation or limb salvage) on local recurrence rates. The relative risk (RR) was calculated to compare outcomes in patients with osteosarcoma with pathologic fractures and those without. Heterogeneity among studies was calculated using the I 2 statistic. The pooled RR was calculated using the fixed-effects or random-effects model depending on study heterogeneity. The fragility index and the ratio between the fragility index and the total number of participants for each outcome was additionally calculated to assess the robustness of our results. A total of 7604 patients with osteosarcoma, 12% of whom (885) had pathologic fractures, were included in our analysis., Results: Pathologic fractures in patients with osteosarcoma were associated with lower 3-year (RR 1.53 [95% CI 1.29 to 1.82]; p < 0.001) and 5-year overall survival (RR 1.27 [95% CI 1.16 to 1.40]; p < 0.001). No difference in recurrence rates was found between patients with osteosarcoma with pathologic fractures and those without (RR 1.22 [95% CI 0.91 to 1.64]; p = 0.18). However, having a pathologic fracture was associated with an increased risk of developing metastasis (RR 1.33 [95% CI 1.08 to 1.63]; p = 0.01). Treatment with limb salvage surgery was not associated with a higher rate of local recurrence (RR 1.58 [95% CI 0.88 to 2.85]; p = 0.13)., Conclusion: In light of these findings, surgeons should be aware that after appropriate case selection, patients with osteosarcoma and pathologic fractures undergoing limb salvage surgery may have similar rates of local recurrence to those undergoing amputation. Therefore, a pathologic fracture may no longer be an absolute contraindication for limb salvage surgery. Future studies adjusting for potential confounders such as tumor size, tumor location, and response to neoadjuvant therapy would provide further insight into the effect of pathologic fractures on our assessed outcomes., Level of Evidence: Level III, therapeutic study., Competing Interests: Each author certifies that there are no funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article related to the author or any immediate family members. All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request., (Copyright © 2023 by the Association of Bone and Joint Surgeons.)
- Published
- 2023
- Full Text
- View/download PDF
3. Development and Validation of a Convolutional Neural Network Model to Predict a Pathologic Fracture in the Proximal Femur Using Abdomen and Pelvis CT Images of Patients With Advanced Cancer.
- Author
-
Joo MW, Ko T, Kim MS, Lee YS, Shin SH, Chung YG, and Lee HK
- Subjects
- Humans, Female, Middle Aged, Aged, Male, Tomography, X-Ray Computed methods, Neural Networks, Computer, Femur, Pelvis, Abdomen, Fractures, Spontaneous diagnostic imaging, Fractures, Spontaneous etiology, Bone Neoplasms complications, Bone Neoplasms diagnostic imaging
- Abstract
Background: Improvement in survival in patients with advanced cancer is accompanied by an increased probability of bone metastasis and related pathologic fractures (especially in the proximal femur). The few systems proposed and used to diagnose impending fractures owing to metastasis and to ultimately prevent future fractures have practical limitations; thus, novel screening tools are essential. A CT scan of the abdomen and pelvis is a standard modality for staging and follow-up in patients with cancer, and radiologic assessments of the proximal femur are possible with CT-based digitally reconstructed radiographs. Deep-learning models, such as convolutional neural networks (CNNs), may be able to predict pathologic fractures from digitally reconstructed radiographs, but to our knowledge, they have not been tested for this application., Questions/purposes: (1) How accurate is a CNN model for predicting a pathologic fracture in a proximal femur with metastasis using digitally reconstructed radiographs of the abdomen and pelvis CT images in patients with advanced cancer? (2) Do CNN models perform better than clinicians with varying backgrounds and experience levels in predicting a pathologic fracture on abdomen and pelvis CT images without any knowledge of the patients' histories, except for metastasis in the proximal femur?, Methods: A total of 392 patients received radiation treatment of the proximal femur at three hospitals from January 2011 to December 2021. The patients had 2945 CT scans of the abdomen and pelvis for systemic evaluation and follow-up in relation to their primary cancer. In 33% of the CT scans (974), it was impossible to identify whether a pathologic fracture developed within 3 months after each CT image was acquired, and these were excluded. Finally, 1971 cases with a mean age of 59 ± 12 years were included in this study. Pathologic fractures developed within 3 months after CT in 3% (60 of 1971) of cases. A total of 47% (936 of 1971) were women. Sixty cases had an established pathologic fracture within 3 months after each CT scan, and another group of 1911 cases had no established pathologic fracture within 3 months after CT scan. The mean age of the cases in the former and latter groups was 64 ± 11 years and 59 ± 12 years, respectively, and 32% (19 of 60) and 53% (1016 of 1911) of cases, respectively, were female. Digitally reconstructed radiographs were generated with perspective projections of three-dimensional CT volumes onto two-dimensional planes. Then, 1557 images from one hospital were used for a training set. To verify that the deep-learning models could consistently operate even in hospitals with a different medical environment, 414 images from other hospitals were used for external validation. The number of images in the groups with and without a pathologic fracture within 3 months after each CT scan increased from 1911 to 22,932 and from 60 to 720, respectively, using data augmentation methods that are known to be an effective way to boost the performance of deep-learning models. Three CNNs (VGG16, ResNet50, and DenseNet121) were fine-tuned using digitally reconstructed radiographs. For performance measures, the area under the receiver operating characteristic curve, accuracy, sensitivity, specificity, precision, and F1 score were determined. The area under the receiver operating characteristic curve was used to evaluate three CNN models mainly, and the optimal accuracy, sensitivity, and specificity were calculated using the Youden J statistic. Accuracy refers to the proportion of fractures in the groups with and without a pathologic fracture within 3 months after each CT scan that were accurately predicted by the CNN model. Sensitivity and specificity represent the proportion of accurately predicted fractures among those with and without a pathologic fracture within 3 months after each CT scan, respectively. Precision is a measure of how few false-positives the model produces. The F1 score is a harmonic mean of sensitivity and precision, which have a tradeoff relationship. Gradient-weighted class activation mapping images were created to check whether the CNN model correctly focused on potential pathologic fracture regions. The CNN model with the best performance was compared with the performance of clinicians., Results: DenseNet121 showed the best performance in identifying pathologic fractures; the area under the receiver operating characteristic curve for DenseNet121 was larger than those for VGG16 (0.77 ± 0.07 [95% CI 0.75 to 0.79] versus 0.71 ± 0.08 [95% CI 0.69 to 0.73]; p = 0.001) and ResNet50 (0.77 ± 0.07 [95% CI 0.75 to 0.79] versus 0.72 ± 0.09 [95% CI 0.69 to 0.74]; p = 0.001). Specifically, DenseNet121 scored the highest in sensitivity (0.22 ± 0.07 [95% CI 0.20 to 0.24]), precision (0.72 ± 0.19 [95% CI 0.67 to 0.77]), and F1 score (0.34 ± 0.10 [95% CI 0.31 to 0.37]), and it focused accurately on the region with the expected pathologic fracture. Further, DenseNet121 was less likely than clinicians to mispredict cases in which there was no pathologic fracture than cases in which there was a fracture; the performance of DenseNet121 was better than clinician performance in terms of specificity (0.98 ± 0.01 [95% CI 0.98 to 0.99] versus 0.86 ± 0.09 [95% CI 0.81 to 0.91]; p = 0.01), precision (0.72 ± 0.19 [95% CI 0.67 to 0.77] versus 0.11 ± 0.10 [95% CI 0.05 to 0.17]; p = 0.0001), and F1 score (0.34 ± 0.10 [95% CI 0.31 to 0.37] versus 0.17 ± 0.15 [95% CI 0.08 to 0.26]; p = 0.0001)., Conclusion: CNN models may be able to accurately predict impending pathologic fractures from digitally reconstructed radiographs of the abdomen and pelvis CT images that clinicians may not anticipate; this can assist medical, radiation, and orthopaedic oncologists clinically. To achieve better performance, ensemble-learning models using knowledge of the patients' histories should be developed and validated. The code for our model is publicly available online at https://github.com/taehoonko/CNN_path_fx_prediction ., Level of Evidence: Level III, diagnostic study., Competing Interests: The institution of one or more of the authors (MWJ) has received, during the study period, funding from the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2021R1F1A1047841). Each author certifies that there are no funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article related to the author or any immediate family members. All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research ® editors and board members are on file with the publication and can be viewed on request., (Copyright © 2023 by the Association of Bone and Joint Surgeons.)
- Published
- 2023
- Full Text
- View/download PDF
4. Are Fibular Allograft Struts Useful for Unicameral Bone Cysts of the Proximal Humerus in Skeletally Mature Patients?
- Author
-
Jamshidi K, Bahradadi M, Bahrabadi M, and Mirzaei A
- Subjects
- Allografts, Humans, Humerus diagnostic imaging, Humerus pathology, Humerus surgery, Pain, Retrospective Studies, Treatment Outcome, Bone Cysts complications, Bone Cysts diagnostic imaging, Bone Cysts surgery, Fractures, Spontaneous etiology
- Abstract
Background: Although most unicameral bone cysts (UBCs) are either successfully treated or have healed by the time of skeletal maturity, a small proportion of patients will have persistent UBCs beyond the age of skeletal maturity. More reliable methods are needed to treat persistent UBCs in the humerus because these cysts are associated with a high risk of fracture due to thinning of the humeral cortex. In this study, we evaluated whether inserting a fibular strut allograft into the humerus would be associated with healing of the cyst and union of associated pathologic fractures in skeletally mature patients with a UBC of the proximal humerus., Questions/purposes: (1) How effective is inserting a fibular strut allograft in the healing of proximal humerus UBCs in skeletally mature patients with bone cysts and associated fractures? (2) What are the functional results of this procedure? (3) What complications are associated with this procedure?, Methods: Between 2005 and 2018, we surgically treated 23 skeletally mature patients with persistent humeral UBCs and any of the following indications: a progressive cyst that was not responsive to aspiration and 2 to 3 steroid injections, a cyst with a pathologic fracture, and a cyst at high risk of fracture. Of those, patients with a cyst located in the proximal humerus and a defect length more than 6 cm (n = 18) were considered eligible to be treated with insertion of a fibular strut allograft through a hole created in the greater tuberosity. A further two patients were excluded because they were treated by other surgical methods. From the remaining 16 patients, two patients were lost to follow-up before 2 years and could not be analyzed in this study. Another two patients had incomplete datasets, leaving 12 for analyses in this retrospective study. Three patients presented with a pathologic fracture. Complete filling of the cysts with bone within 24 months was regarded as healing, and after 24 months it was classified as delayed healing. Cyst consolidation with small residual areas of osteolysis was considered healed with residual radiographic appearance. Fracture union was determined by the clear observation of at least three of four cortical views bridged by bone in the radiographic follow-up 3 months after the operation. Fractures in which the cortices were not bridged by bone after 3 months were regarded as a delayed union. The functional outcome of the patients was assessed by the Musculoskeletal Tumor Society (MSTS) scoring system, with a total score ranging from 0 to 30. A higher score was indicative of less pain and better function. MSTS scores were obtained through a chart review by an orthopaedist who was not involved in the care administered., Results: At a median (range) follow-up of 57 months (33 to 87), the cyst was completely healed in nine patients and healed with residual cyst in the remaining three. Union was observed within 3 months in all patients who presented with a pathologic fracture. The median MSTS score of the patients was 30 (28 to 30). No postoperative complications such as persistent pain or re-fracture were observed., Conclusion: The primary goal of treating a UBC of the proximal humerus is to prevent fracture of the affected bone; insertion of a fibular strut graft in this study met this goal. Therefore, we believe a fibular strut allograft insertion is worth consideration when treating proximal humeral UBCs in skeletally mature patients. Further studies will be needed to determine whether this approach has benefits compared with other treatment options., Level of Evidence: Level IV, therapeutic study., Competing Interests: Each author certifies that there are no funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article related to the author or any immediate family members. All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request., (Copyright © 2021 by the Association of Bone and Joint Surgeons.)
- Published
- 2022
- Full Text
- View/download PDF
5. What Factors Are Associated With Local Metastatic Lesion Progression After Intramedullary Nail Stabilization?
- Author
-
Arpornsuksant P, Morris CD, Forsberg JA, and Levin AS
- Subjects
- Bone Nails adverse effects, Child, Disease Progression, Female, Humans, Male, Quality of Life, Retrospective Studies, Treatment Outcome, Carcinoma, Renal Cell, Fracture Fixation, Intramedullary, Fractures, Bone etiology, Fractures, Spontaneous diagnostic imaging, Fractures, Spontaneous etiology, Fractures, Spontaneous surgery, Kidney Neoplasms
- Abstract
Background: Pathologic fracture of the long bones is a common complication of bone metastases. Intramedullary nail stabilization can be used prophylactically (for impending fractures) or therapeutically (for completed fractures) to preserve mobility and quality of life. However, local disease progression may occur after such treatment, and there is concern that surgical instrumentation and the intramedullary nail itself may seed tumor cells along the intramedullary tract, ultimately leading to loss of structural integrity of the construct. Identifying factors associated with local disease progression after intramedullary nail stabilization would help surgeons predict which patients may benefit from alternative surgical strategies., Questions/purposes: (1) Among patients who underwent intramedullary nail stabilization for impending or completed pathologic fractures of the long bones, what is the risk of local progression, including progression of the existing lesion and development of a new lesion around the nail? (2) Among patients who experience local progression, what proportion undergo reoperation? (3) What patient characteristics and treatment factors are associated with postoperative local progression? (4) What is the difference in survival rates between patients who experienced local progression and those with stable local disease?, Methods: Between January 2013 and December 2019, 177 patients at our institution were treated with an intramedullary nail for an impending or completed pathologic fracture. We excluded patients who did not have a pathologic diagnosis of metastasis before fixation, who were younger than 18 years of age, who presented with a primary soft tissue mass that eroded into bone, and who experienced nonunion from radiation osteitis or an avulsion fracture rather than from metastasis. Overall, 122 patients met the criteria for our study. Three fellowship-trained orthopaedic oncology surgeons involved in the care of these patients treated an impending or pathologic fracture with an intramedullary nail when a long bone lesion either fractured or was deemed to be of at least 35% risk of fracture within 3 months, and in patients with an anticipated duration of overall survival of at least 6 weeks (fractured) or 3 months (impending) to yield palliative benefit during their lifetime. The most common primary malignancy was multiple myeloma (25% [31 of 122]), followed by lung carcinoma (16% [20 of 122]), breast carcinoma (15% [18 of 122]), and renal cell carcinoma (12% [15 of 122]). The most commonly involved bone was the femur (68% [83 of 122]), followed by the humerus (27% [33 of 122]) and the tibia (5% [6 of 122]). A competing risk analysis was used to determine the risk of progression in our patients at 1 month, 3 months, 6 months, and 12 months after surgery. A proportion of patients who ultimately underwent reoperation due to progression was calculated. A univariate analysis was performed to determine whether lesion progression was associated with various factors, including the age and sex of the patient, use of adjuvant therapies (radiation therapy at the site of the lesion, systemic therapy, and antiresorptive therapy), histologic tumor type, location of the lesion, and fracture type (impending or complete). Patient survival was assessed with a Kaplan-Meier curve. A p value < 0.05 was considered significant., Results: The cumulative incidence of local tumor progression (with death as a competing risk) at 1 month, 3 months, 6 months, and 12 months after surgery was 1.9% (95% confidence interval 0.3% to 6.1%), 2.9% (95% CI 0.8% to 7.5%), 3.9% (95% CI 1.3% to 8.9%), and 4.9% (95% CI 1.8% to 10.3%), respectively. Of 122 patients, 6% (7) had disease progression around the intramedullary nail and 0.8% (1) had new lesions at the end of the intramedullary nail. Two percent (3 of 122) of patients ultimately underwent reoperation because of local progression. The only factors associated with progression were a primary tumor of renal cell carcinoma (odds ratio 5.1 [95% CI 0.69 to 29]; p = 0.03) and patient age (difference in mean age 7.7 years [95% CI 1.2 to 14]; p = 0.02). We found no associations between local disease progression and the presence of visceral metastases, other skeletal metastases, radiation therapy, systemic therapy, use of bisphosphonate or receptor activator of nuclear factor kappa-B ligand inhibitor, type of fracture, or the direction of nail insertion. There was no difference in survivorship curves between those with disease progression and those with stable local disease (= 0.36; p = 0.54)., Conclusion: Our analysis suggests that for this population of patients with metastatic bone disease who have a fracture or impeding fracture and an anticipated survival of at least 6 weeks (completed fracture) or 3 months (impending fracture), the risk of experiencing local progression of tumor growth and reoperations after intramedullary nail stabilization seems to be low. Lesion progression was not associated with the duration of survival, although this conclusion is limited by the small number of patients in the current study and the competing risks of survival and local progression. Based on our data, patients who present with renal cell carcinoma should be cautioned against undergoing intramedullary nailing because of the risk of postoperative lesion progression., Level of Evidence: Level III, therapeutic study., Competing Interests: Each author certifies that there are no funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article related to the author or any immediate family members. All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request., (Copyright © 2021 by the Association of Bone and Joint Surgeons.)
- Published
- 2022
- Full Text
- View/download PDF
6. Can a Novel Scoring System Improve on the Mirels Score in Predicting the Fracture Risk in Patients with Multiple Myeloma?
- Author
-
Toci GR, Bressner JA, Morris CD, Fayad L, and Levin AS
- Subjects
- Aged, Area Under Curve, Female, Humans, Male, Middle Aged, Predictive Value of Tests, ROC Curve, Retrospective Studies, Risk Assessment methods, Risk Factors, Algorithms, Fractures, Spontaneous etiology, Multiple Myeloma complications, Radiography statistics & numerical data, Risk Assessment statistics & numerical data
- Abstract
Background: Stratification of the fracture risk is an important treatment component for patients with multiple myeloma, which is associated with up to an 80% risk of pathologic fracture. The Mirels score, which is commonly used to estimate the fracture risk for patients with osseous lesions, was evaluated in a cohort in which fewer than 15% of lesions were caused by multiple myeloma. The behavior of multiple myeloma lesions often differs from that of lesions caused by metastatic disease, and accurate risk stratification is critical for effective care. To our knowledge, the Mirels score has not been validated specifically for multiple myeloma., Questions/purposes: Our purpose was: (1) To develop a novel scoring system for the prediction of pathologic fracture in patients with long-bone lesions from multiple myeloma; and (2) to compare the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and receiver operating characteristic (ROC) area under curve (AUC) between the novel scoring system and the Mirels system., Methods: Between 2003 and 2017, 763 patients at one center with the diagnosis of multiple myeloma were reviewed, of whom 174 presented with long-bone disease involvement. Of those, 5% (nine of 174) were missing data or radiographs at a minimum of 1 year and had not reached an endpoint (fracture or surgery) before that time and were therefore excluded. Many patients have more than one lesion; consequently, we used the largest lesion in each patient, resulting in 163 lesions in as many patients. Ten percent (16 of 163) of these patients eventually developed a fracture and 4% (six of 163) underwent prophylactic stabilization (excluded from analysis because of outcome uncertainty). During the study period, prophylactic stabilization was performed at the discretion of the orthopaedic oncologist. Fifty-one percent (83 of 163) of patients were female, and the mean (± SD) age was 60 ± 10 years at radiographic lesion identification. All lesions were characterized before determining whether the patient underwent pathologic fracture. We identified variables associated with pathologic fracture on univariate analysis. Variables independently significant on logistic regression analysis were used to generate scoring algorithms at varying weights and scoring cutoffs for comparison via ROC curves. We then selected a novel score based on ROC performance, and compared the sensitivity, specificity, PPV, and NPV of that scoring system to that of Mirels score. ROC AUCs were compared after bootstrapping 100,000 iterations. Alpha was set at 0.05., Results: After controlling for potential confounders, such as age, sex, and duration of myeloma diagnosis, we found the following factors were independently associated with the occurrence of pathologic fracture: larger lesion size (area, cm2) (log odds 0.17; p = 0.03), longer lesion latency (years from diagnosis to lesion identification) (log odds 0.25; p = 0.03), presence of pain (relative risk [RR] 2.9; p = 0.04), and metaphyseal location (RR 3.2, compared with epiphyseal or diaphyseal; p = 0.003). These variables were used to formulate a novel scoring system. Compared with the Mirels system, the novel system was more sensitive (69% [95% CI 61 to 76] versus 38% [95% CI 30 to 46]; p < 0.05) but not different in terms of specificity (87% [95% CI 80 to 91] versus 87% [95% CI 81 to 92]; p > 0.05), PPV (37% [95% CI 29 to 45] versus 25% [95% CI 19 to 33]; p > 0.05), NPV (96% [95% CI 91 to 99] versus 92% [95% CI 87 to 96]; p > 0.05), or AUC (0.85 [95% CI 0.74 to 0.92] versus 0.67 [95% CI 0.51 to 0.81]; p > 0.05)., Conclusion: The novel scoring system was found to be more sensitive than the Mirels system for predicting pathologic fracture in our retrospective cohort of patients with multiple myeloma-related bone disease. Specificity, PPV, NPV, and ROC AUC were not different with the numbers available. Thus, the novel scoring system may serve as a more effective screening tool to determine which patients with multiple myeloma would benefit from further radiologic or orthopaedic evaluation based on a skeletal survey., Level of Evidence: Level III, diagnostic study., Competing Interests: Each author certifies that neither he nor she, nor any member of his or her immediate family, has funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article. All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request., (Copyright © 2020 by the Association of Bone and Joint Surgeons.)
- Published
- 2021
- Full Text
- View/download PDF
7. What Is the Adverse Event Profile After Prophylactic Treatment of Femoral Shaft or Distal Femur Metastases?
- Author
-
McLynn RP, Ondeck NT, Grauer JN, and Lindskog DM
- Subjects
- Aged, Blood Transfusion statistics & numerical data, Databases, Factual, Diaphyses pathology, Diaphyses surgery, Female, Femoral Fractures etiology, Femur pathology, Femur surgery, Fracture Fixation methods, Fractures, Spontaneous etiology, Humans, Length of Stay statistics & numerical data, Logistic Models, Male, Middle Aged, Multivariate Analysis, Odds Ratio, Operative Time, Patient Discharge statistics & numerical data, Postoperative Complications epidemiology, Postoperative Complications pathology, Prospective Studies, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Femoral Fractures prevention & control, Fracture Fixation adverse effects, Fractures, Spontaneous prevention & control, Neoplasm Metastasis prevention & control, Postoperative Complications etiology
- Abstract
Background: Prophylactic surgical treatment of the femur is commonly offered to patients with metastatic disease who have a high risk of impending pathologic fracture. Prophylactic fixation is associated with improved functional outcomes in appropriate patients selected based on established criteria, but the perioperative complication profile has received little attention. Given the substantial comorbidity in this population, it is important to characterize surgical risks for surgeons and patients to improve treatment decisions., Questions/purposes: (1) What is the incidence of postoperative adverse events after prophylactic surgical stabilization of metastatic lesions of the femoral shaft or distal femur? (2) How does this complication profile compare with stabilization of pathologic fractures adjusted for differences in patient demographics and comorbidity?, Methods: We performed a retrospective study using the National Surgical Quality Improvement Program (NSQIP) database. We identified patients undergoing prophylactic treatment of the femoral shaft or distal femur by Current Procedural Terminology (CPT) codes. Patients undergoing treatment of a pathologic fracture were identified by CPT code for femur fracture fixation as well as an International Classification of Diseases code indicating neoplasm or pathologic fracture. We tracked adverse events, operative time, blood transfusion, hospital length of stay, and discharge to a facility within 30 days postoperatively. There were 332 patients included in the prophylactic treatment group and 288 patients in the pathologic fracture group. Patients in the prophylactic treatment group presented with greater body mass index (BMI), whereas the pathologic fracture group presented with a greater incidence of disseminated cancer. The odds of experiencing adverse events were initially compared between the two groups using bivariate logistic regression and then using multivariate regression controlling for age, sex, BMI, and American Society of Anesthesiologists (ASA) class and disseminated cancer causing marked physiological compromise per NSQIP guidelines., Results: With multivariate analysis controlling for age, sex, BMI, and ASA class, patients with pathologic fracture were more likely to experience any adverse event (odds ratio [OR], 1.53; 95% confidence interval [CI], 1.03-2.29; p = 0.036), major adverse events (OR, 1.61; 95% CI, 1.01-2.55; p = 0.043), death (OR, 1.90; 95% CI, 1.07-3.38; p = 0.030), blood transfusion (OR, 1.57; 95% CI, 1.08-2.27; p = 0.017), and hospital stay ≥ 9 days (OR, 1.51; 95% CI, 1.05-2.19; p = 0.028) compared with patients undergoing prophylactic treatment. However, when additionally controlling for disseminated cancer, the only difference was that patients with pathologic fractures were more likely to receive a blood transfusion than were patients undergoing prophylactic fixation (OR, 1.61; 95% CI, 1.12-2.36; p = 0.011)., Conclusions: After controlling for differences in patient characteristics, prophylactic treatment of femoral metastases was associated with a decreased likelihood of blood transfusion and no differences in terms of the frequency of other adverse events. In the context of prior studies supporting the mechanical and functional outcomes of prophylactic treatment, the findings of this cohort suggest that the current guidelines have achieved a reasonable balance of morbidity in patients with femoral lesions and further support the current role of prophylactic treatment of impending femur fractures in appropriately selected patients., Level of Evidence: Level III, therapeutic study.
- Published
- 2018
- Full Text
- View/download PDF
8. Is a Cephalomedullary Nail Durable Treatment for Patients With Metastatic Peritrochanteric Disease?
- Author
-
Chafey DH, Lewis VO, Satcher RL, Moon BS, and Lin PP
- Subjects
- Female, Femoral Fractures etiology, Femoral Neoplasms pathology, Femoral Neoplasms surgery, Fracture Fixation, Intramedullary adverse effects, Fractures, Spontaneous etiology, Hip Fractures etiology, Humans, Incidence, Male, Postoperative Complications epidemiology, Postoperative Complications etiology, Reoperation statistics & numerical data, Retrospective Studies, Risk Factors, Treatment Outcome, Bone Nails adverse effects, Femoral Fractures surgery, Fracture Fixation, Intramedullary instrumentation, Fractures, Spontaneous surgery, Hip Fractures surgery
- Abstract
Background: Although cephalomedullary nail fixation is often used for metastatic peritrochanteric lesions of the femur, there is concern regarding the durability of the implant in comparison to endoprosthetic reconstruction. Previous studies have reported the proportion of patients who undergo reoperation for loss of stability, but the adequacy of the construct has not been critically evaluated in a competing risk analysis that incorporates death of the patient in the calculation., Questions/purposes: (1) What is the cumulative incidence of reoperation of cephalomedullary nails with death as a competing risk for metastatic lesions of the proximal femur? (2) What is the survival of patients with metastases to the proximal femur after cephalomedullary nailing? (3) What clinical factors are associated with implant stability in these patients?, Methods: Between 1990 and 2009, 11 surgeons at one center treated 217 patients with cephalomedullary nails for metastatic proximal femoral lesions. This represented 40% (217 of 544) of the patients undergoing surgery for metastases in this location during the study period. In general, we used cephalomedullary nails when there was normal bone in the femoral head, no fracture in the neck, and a moderate-sized lesion; we favored bipolar hemiarthroplasty for femoral neck fractures and disease affecting the femoral head; finally, we used proximal femoral endoprosthetic replacement for large lesions with severe bone destruction. A retrospective study was conducted of 199 patients with cephalomedullary nails for peritrochanteric metastases from 1990 to 2009. Pathologic fracture, defined as a breach in cortex with a clear fracture line either with or without displacement, was present in 61 patients. The most common primary cancers were breast (42 of 199 patients [21%]), lung (37 of 199 patients [18%]), and renal cell (34 of 199 patients [17%]). A competing risk analysis was performed to describe the cumulative incidence of implant revision. Patient overall survival was assessed by Kaplan-Meier survivorship. A univariate analysis was performed to determine whether there was an association between revision surgery and various patient factors, including tumor histology, pathologic fracture, cementation, and radiation., Results: Loss of implant stability necessitating revision surgery occurred in 19 of 199 patients (10%). In a competing risk analysis with death of the patient as the competing event, the cumulative incidence of revision surgery was 5% (95% confidence interval [CI], 3%-9%) at 12 months and 9% (95% CI, 5%-13%) at 5 years. Using Kaplan-Meier analysis, the overall patient survival was 31% (95% CI, 25%-37%) at 12 months and 5% (95% CI, 3%-9%) at 60 months. Patients with lung cancer had the shortest overall survival of 11% (95% CI, 1%-21%) at 12 months, and patients with multiple myeloma had the longest overall survival of 71% (95% CI, 49%-94%) at 12 months (p < 0.001). Duration of patient survival beyond the median 7 months was the only factor associated with a greater likelihood of revision surgery. Factors not associated with revision included tumor histology, pathologic fracture, closed versus open nailing, cementation, gender, age, and postoperative radiation., Conclusions: The competing risk analysis demonstrates a relatively low cumulative incidence of reoperation and suggests that cephalomedullary nailing is reasonable for patients with moderate-sized proximal femoral metastasis not affecting the femoral head. For the large majority of patients, the construct achieves the goal of stabilizing the femur for the duration of the patient's life. Longer patient survival was associated with greater risk of revision surgery, but no particular tumor histology was found to have a greater cumulative incidence of reoperation. Future work with a larger number of patients and stricter surgical indications may be needed to corroborate these findings., Level of Evidence: Level III, therapeutic study.
- Published
- 2018
- Full Text
- View/download PDF
9. High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients.
- Author
-
Groot OQ, Ogink PT, Janssen SJ, Paulino Pereira NR, Lozano-Calderon S, Raskin K, Hornicek F, and Schwab JH
- Subjects
- Aged, Bone Neoplasms complications, Bone Neoplasms mortality, Bone Neoplasms secondary, Boston, Female, Fractures, Spontaneous diagnosis, Fractures, Spontaneous etiology, Fractures, Spontaneous mortality, Humans, Male, Middle Aged, Osteotomy mortality, Pulmonary Embolism diagnosis, Pulmonary Embolism mortality, Pulmonary Embolism prevention & control, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, Venous Thromboembolism diagnosis, Venous Thromboembolism mortality, Venous Thromboembolism prevention & control, Venous Thrombosis diagnosis, Venous Thrombosis mortality, Venous Thrombosis prevention & control, Bone Neoplasms surgery, Fractures, Spontaneous surgery, Osteotomy adverse effects, Pulmonary Embolism etiology, Venous Thromboembolism etiology, Venous Thrombosis etiology
- Abstract
Background: Previous studies have shown that venous thromboembolism (VTE) is a complication associated with neoplastic disease and major orthopaedic surgery. However, many potential risk factors remain undefined., Questions/purposes: (1) What proportion of patients develop symptomatic VTE after surgery for long bone metastases? (2) What factors are associated with the development of symptomatic VTE among patients receiving surgery for long bone metastases? (3) Is there an association between the development of symptomatic VTE and 1-year survival among patients undergoing surgery for long bone metastases? (4) Does chemoprophylaxis increase the risk of wound complications among patients undergoing surgery for long bone metastases?, Methods: A retrospective study identified 682 patients undergoing surgical treatment of long bone metastases between 2002 and 2013 at the Massachusetts General Hospital and Brigham and Women's Hospital. We included patients 18 years of age or older who had a surgical procedure for impending or pathologic metastatic long bone fracture. We considered the humerus, radius, ulna, femur, tibia, and fibula as long bones; metastatic disease was defined as metastases from solid organs, multiple myeloma, or lymphoma. In general, we used 40 mg enoxaparin daily for lower extremity surgery and 325 mg aspirin daily for lower or upper extremity surgery. The primary outcome was a VTE defined as any symptomatic pulmonary embolism (PE) or symptomatic deep vein thrombosis (DVT; proximal and distal) within 90 days of surgery as determined by chart review. The tertiary outcome was defined as any documented wound complication that might be attributable to chemoprophylaxis within 90 days of surgery. At followup after 90 days and 1 year, respectively, 4% (25 of 682) and 8% (53 of 682) were lost to followup. Statistical analysis was performed using multivariable logistic and Cox regression and Kaplan-Meier., Results: Overall, 6% (44 of 682) of patients had symptomatic VTE; 22 patients sustained a DVT, and 22 developed a PE. After controlling for relevant confounding variables, higher preoperative hemoglobin level was independently associated (odds ratio [OR], 0.75; 95% confidence interval [CI], 0.60-0.93; p = 0.011) with decreased symptomatic VTE risk, the presence of symptomatic VTE was associated with a worse 1-year survival rate (VTE: 27% [95% CI, 14%-40%] and non-VTE: 39% [95% CI, 35%-43%]; p = 0.041), and no association was found between wound complications and the use of chemoprophylaxis (OR, 3.29; 95% CI, 0.43-25.17; p = 0.252)., Conclusions: The risk of symptomatic 90-day VTE is high in patients undergoing surgery for long bone metastases. Further study would be needed to determine the VTE prevention strategy that best balances risks and benefits to address this complication., Level of Evidence: Level III, therapeutic study.
- Published
- 2018
- Full Text
- View/download PDF
10. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
- Author
-
Sørensen MS, Gerds TA, Hindsø K, and Petersen MM
- Subjects
- Area Under Curve, Bone Neoplasms secondary, Cross-Sectional Studies, Databases, Factual, Denmark, Extremities pathology, Extremities surgery, Female, Fractures, Spontaneous etiology, Fractures, Spontaneous mortality, Fractures, Spontaneous surgery, Humans, Logistic Models, Male, Nomograms, Prognosis, Prospective Studies, ROC Curve, Treatment Outcome, Arthroplasty, Replacement mortality, Bone Neoplasms mortality, Bone Neoplasms surgery, Fracture Fixation, Internal mortality, Models, Statistical
- Abstract
Background: Survival predictions before surgery for metastatic bone disease in the extremities (based on statistical models and data of previous patients) are important for choosing an implant that will function for the remainder of the patient's life. The 2008-SPRING model, presented in 2016, enables the clinician to predict expected survival before surgery for metastatic bone disease in the extremities. However, to maximize the model's accuracy, it is necessary to maintain and update the patient database to refit the prediction models achieving more accurate calibration., Questions/purposes: The purposes of this study were (1) to refit the 2008-SPRING model for prediction of survival before surgery for metastatic bone disease in the extremities with a more modern cohort; and (2) to evaluate the performance of the refitted SPRING model in a population-based cohort of patients having surgery for metastatic bone disease in the extremities., Methods: We produced the 2013-SPRING model by adding to the 2008-SPRING model (n = 130) a cohort of patients from a consecutive institutional database of patients who underwent surgery for bone metastases in the extremities with bone resection and reconstruction between 2009 and 2013 at a highly specialized surgical center in Denmark (n = 140). Currently the model is only available as the nomogram fully available in the current article, which is sufficient to use in daily clinical work, but we are working on making the tool available online. As such, the 2013-SPRING model was produced using a consecutive cohort of patients (n = 270) treated during an 11-year period (2003-2013) called the training cohort, all treated with bone resection and reconstruction. We externally validated the 2008-SPRING and the 2013-SPRING models in a prospective cohort (n = 164) of patients who underwent surgery for metastatic bone disease in the extremities from May 2014 to May 2016, called the validation cohort. The validation cohort was identified from a cross-section of the Danish population who were treated for metastatic lesions (using endoprostheses and internal fixation) in the extremities at five secondary surgical centers and one highly specialized surgical center. This cross-section is representative of the Danish population and no patients were treated outside the included centers as a result of public healthcare settings. The indications for surgery for training and the validation cohort were pathologic fracture, impending fracture, or intractable pain despite radiation. Exact date of death was known for all patients as a result of the Danish Civil Registration System and no loss to followup existed. In the training cohort, 150 patients (out of 270 [56%]) and in the validation cohort 97 patients (out of 164 [59%]) died of disease within 1 year postoperatively. The 2013 model did not differ from the 2008 model and included hemoglobin, complete fracture/impending fracture, visceral and multiple bone metastases, Karnofsky Performance Status, and the American Society of Anesthesiologists score and primary cancer. The models were evaluated by area under the receiver operating characteristic curve (AUC ROC) and Brier score (the lower the better)., Results: The 2013-SPRING model was successfully refitted with a cohort using more patients than the 2008-SPRING model. Comparison of performance in external validation between the 2008 and 2013-SPRING models showed the AUC ROC was increased by 3% (95% confidence interval [CI], 0%-5%; p = 0.027) and 2% (95% CI, 0%-4%; p = 0.013) at 3-month and 6-month survival predictions, respectively, but not at 12 months at 1% (95% CI, 0%-3%; p = 0.112). Brier score was improved by -0.018 (95% CI, -0.032 to -0.004; p = 0.011) for 3-month, -0.028 (95% CI, -0.043 to -0.0123; p < 0.001) for 6-month, and -0.014 (95% CI, -0.025 to -0.002; p = 0.017) for 12-month survival prediction., Conclusions: We improved the SPRING model's ability to predict survival after surgery for metastatic bone disease in the extremities. As such, the refitted 2013-SPRING model gives the surgeon a tool to assist in the decision-making of a surgical implant that will serve the patient for the remainder of their life. The 2013-SPRING model may provide increased quality of life for patients with bone metastasis because potential implant failures can be minimized by precise survival prediction preoperatively and the model is freely available and ready to use from the current article., Level of Evidence: Level I, diagnostic study.
- Published
- 2018
- Full Text
- View/download PDF
11. Early Improvement in Pain and Functional Outcome but Not Quality of Life After Surgery for Metastatic Long Bone Disease.
- Author
-
Nooh A, Goulding K, Isler MH, Mottard S, Arteau A, Dion N, and Turcotte R
- Subjects
- Aged, Bone Neoplasms complications, Bone Neoplasms secondary, Female, Fractures, Bone etiology, Fractures, Bone physiopathology, Fractures, Bone psychology, Fractures, Spontaneous etiology, Fractures, Spontaneous physiopathology, Fractures, Spontaneous psychology, Humans, Male, Middle Aged, Pain etiology, Pain physiopathology, Pain psychology, Pain Measurement, Prospective Studies, Quebec, Radiotherapy, Adjuvant, Recovery of Function, Risk Factors, Time Factors, Treatment Outcome, Bone Neoplasms surgery, Fractures, Bone surgery, Fractures, Spontaneous surgery, Orthopedic Procedures adverse effects, Pain prevention & control, Quality of Life
- Abstract
Background: Bone metastases represent the most frequent cause of cancer-related pain, affecting health-related quality of life and creating a substantial burden on the healthcare system. Although most bony metastatic lesions can be managed nonoperatively, surgical management can help patients reduce severe pain, avoid impending fracture, and stabilize pathologic fractures. Studies have demonstrated functional improvement postoperatively as early as 6 weeks, but little data exist on the temporal progress of these improvements or on the changes in quality of life over time as a result of surgical intervention., Questions/purposes: (1) Do patients' functional outcomes, pain, and quality of life improve after surgery for long bone metastases? (2) What is the temporal progress of these changes to 1 year after surgery or death? (3) What is the overall and 30-day rate of complications after surgery for long bone metastases? (4) What are the oncologic outcomes including overall survival and local disease recurrence for this patient population?, Methods: A multicenter, prospective study from three orthopaedic oncology centers in Quebec, Canada, was conducted between 2008 and 2016 to examine the improvement in function and quality of life after surgery for patients with long bone metastases. During this time, 184 patients out of a total of 210 patients evaluated during this period were enrolled; of those, 141 (77%) had complete followup at a minimum of 2 weeks (mean, 23 weeks; range, 2-52 weeks) or until death, whereas another 35 (19%) were lost to followup but were not known to have died before the minimum followup interval was achieved. Pathologic fracture was present in 34% (48 of 141) of patients. The median Mirel's score for those who underwent prophylactic surgery was 10 (interquartile range, 10-11). Surgical procedures included intramedullary nailing (55), endoprosthetic replacement (49), plate osteosynthesis (31), extended intralesional curettage (four), and allograft reconstruction (two). Seventy-seven percent (108 of 141) of patients received radiotherapy. The Musculoskeletal Tumor Society (MSTS), Toronto Extremity Salvage Score (TESS), Brief Pain Inventory (BPI) form, and Quality Of Life During Serious Illness (QOLLTI-P) form were administered pre- and postoperatively at 2 weeks, 6 weeks, 3 months, 6 months, and 1 year. Analysis of variance followed by post hoc analysis was conducted to test for significance between pre- and postoperative scores. The Kaplan-Meier estimate was used to calculate overall survivorship and local recurrence-free survival. A p value of < 0.05 was considered statistically significant., Results: MSTS and BPI pain scores improved at 2 weeks when compared with preoperative scores (MSTS: 39% ± 24% pre- versus 62% ± 19% postoperative, mean difference [MD] 23, 95% confidence interval [CI], 16-32, p < 0.001; BPI: 52% ± 21% pre- versus 30% ± 21% postoperative, MD 22, 95% CI, 16-32, p < 0.001). Continuous and incremental improvement in TESS, MSTS, and BPI scores was observed temporally at 6 weeks, 3 months, 6 months, and 1 year; for example, the TESS score improved from 44% ± 24% to 73% ± 21% (MD 29, p < 0.001, 95% CI, 19-38) at 6 months. We did not detect a difference in quality of life as measured by the QOLLTI-P score (6 ± 1 pre- versus 7 ± 4 postoperative, MD 1, 95% CI, -0.4 to 3, p = 0.2). The overall and 30-day rates of systemic complications were 35% (49 of 141) and 14% (20 of 141), respectively. The Kaplan-Meier estimates for overall survival were 70% (95% CI, 62.4-78) at 6 months and 41% (95% CI, 33-49) at 1 year. Local recurrence-free survival was 17 weeks (95% CI, 11-24)., Conclusions: Surgical management of metastatic long bone disease substantially improves patients' functional outcome and pain as early as 2 weeks postoperatively and should be considered for impending or pathologic fracture in patients whose survival is expected to be longer than 2 weeks provided that there are no immediate contraindications. Quality of life in this patient population did not improve, which may be a function of patient selection, concomitant chemoradiotherapy regimens, disease progression, or terminal illness, and this merits further investigation., Level of Evidence: Level II, therapeutic study.
- Published
- 2018
- Full Text
- View/download PDF
12. Not All Patients Undergoing Stabilization of Impending Pathologic Fractures for Renal Cell Carcinoma Metastases to the Femur Need Preoperative Embolization.
- Author
-
Jernigan EW, Tennant JN, and Esther RJ
- Subjects
- Aged, Blood Loss, Surgical prevention & control, Blood Transfusion, Carcinoma, Renal Cell secondary, Carcinoma, Renal Cell surgery, Databases, Factual, Embolization, Therapeutic adverse effects, Female, Femoral Fractures etiology, Femoral Fractures pathology, Femoral Neoplasms secondary, Femoral Neoplasms surgery, Fracture Fixation adverse effects, Fractures, Spontaneous etiology, Fractures, Spontaneous pathology, Humans, Male, Postoperative Hemorrhage prevention & control, Preoperative Care adverse effects, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Carcinoma, Renal Cell therapy, Embolization, Therapeutic methods, Femoral Fractures prevention & control, Femoral Neoplasms therapy, Fracture Fixation methods, Fractures, Spontaneous prevention & control, Kidney Neoplasms pathology, Preoperative Care methods
- Abstract
Background: Preoperative transarterial embolization has been utilized in the surgical treatment of metastatic renal cell carcinoma of the femur to decrease perioperative blood loss. However, few studies have documented its efficacy in decreasing the proportion of patients receiving transfusions in the setting of prophylactic treatment of impending pathologic femur fractures., Questions/purposes: In a population of patients with metastatic renal cell carcinoma of the femur who underwent prophylactic fixation, the purpose of this study was to quantify and compare the proportion of patients who received at least one transfused unit of blood between a group treated with preoperative embolization and a group without preoperative embolization., Methods: A retrospective study was performed using a Medicare claims-based database. International Classification of Diseases, 9 Revision and Current Procedural Terminology codes were used to identify 1285 patients with metastatic renal cell carcinoma of the femur who underwent prophylactic fixation. The proportion of patients who received one or more blood transfusions was compared between 135 patients who underwent preoperative embolization and a group of 1150 concurrent control patients who did not undergo preoperative embolization. The control group was older than the embolization group, with 44% of these patients > 75 years old and 33% of the embolization group > 75 years. There was no difference in the female:male ratio between groups. Statistical comparisons of outcomes related to transfusion percentages were performed using Pearson chi square analysis with p < 0.05 considered significant. With the numbers available, we had 80% power to detect a difference in the percentage of patients transfused of 11% between the study groups at α = 0.05., Results: No difference in transfusion percentage was observed between preoperative transarterial embolization (41 of 135 [30%]) and the control group (359 of 1150 [31%]; relative risk, 0.973; 95% confidence interval, 0.743-1.274; p = 0.84). The percentage of all patients who received a transfusion was 31% (400 of 1285)., Conclusions: Preoperative embolization may not be mandatory in the prophylactic treatment of metastatic renal cell carcinoma of the femur, as demonstrated by the 69% of patients who received zero units of blood despite not receiving embolization. However, assessment of the efficacy of embolization in decreasing blood loss in the current study is limited as a result of biases associated with the database design of the study; the decision of whether to send a patient for embolization should be made on a case-by-case basis. The current study does not identify specific risk factors that should factor into this decision and underscores the need for further research in this regard. A plausible future research design to account for the low numbers and selection bias that limited the current study as well as the existing studies might be a multicenter, retrospective case-control study., Level of Evidence: Level III, therapeutic study.
- Published
- 2018
- Full Text
- View/download PDF
13. Is Prophylactic Intervention More Cost-effective Than the Treatment of Pathologic Fractures in Metastatic Bone Disease?
- Author
-
Blank AT, Lerman DM, Patel NM, and Rapp TB
- Subjects
- Adult, Aged, Bone Neoplasms complications, Bone Neoplasms secondary, Cost Savings, Cost-Benefit Analysis, Female, Fracture Fixation, Internal adverse effects, Fracture Fixation, Internal methods, Fractures, Spontaneous diagnostic imaging, Fractures, Spontaneous etiology, Health Resources economics, Health Resources statistics & numerical data, Humans, Length of Stay economics, Male, Middle Aged, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Bone Neoplasms economics, Bone Neoplasms surgery, Fracture Fixation, Internal economics, Fractures, Spontaneous economics, Fractures, Spontaneous prevention & control, Hospital Costs
- Abstract
Background: Metastatic bone disease is a substantial burden to patients and the healthcare system as a whole. Metastatic disease can be painful, is associated with decreased survival, and is emotionally traumatic to patients when they discover their disease has progressed. In the United States, more than 250,000 patients have metastatic bone disease, with an estimated annual cost of USD 12 billion. Prior studies suggest that patients who receive prophylactic fixation for impending pathologic fractures, compared with those treated for realized pathologic fractures, have decreased pain levels, faster postoperative rehabilitation, and less in-hospital morbidity. However, to our knowledge, the relative economic utility of these treatment options has not been examined., Questions/purposes: We asked: (1) Is there a cost difference between a cohort of patients treated surgically for pathologic fractures compared with a cohort of patients treated prophylactically for impending pathologic lesions? (2) Do these cohorts differ in other ways regarding their utilization of healthcare resources?, Methods: We performed a retrospective study of 40 patients treated our institution. Between 2011 and 2014, we treated 46 patients surgically for metastatic lesions of long bones. Of those, 19 (48%) presented with pathologic fractures; the other 21 patients (53%) underwent surgery for impending fractures. Risk of impending fracture was determined by one surgeon based on appearance of the lesion, subjective symptoms of the patient, cortical involvement, and location of the lesion. At 1 year postoperative, four patients in each group had died. Six patients (13%) were treated for metastatic disease but were excluded from the retrospective data because of a change in medical record system and inability to obtain financial records. Variables of interest included total and direct costs per episode of care, days of hospitalization, discharge disposition, 1-year postoperative mortality, and descriptive demographic data. All costs were expressed as a cost ratio between the two cohorts, and total differences between the groups, as required per medical center regulations. All data were collected by one author and the medical center's financial office., Results: Mean total cost was higher in patients with pathologic fractures (cost unit [CU], 642 ± 519) than those treated prophylactically without fractures (CU, 370 ± 171; mean difference, 272; 95% CI, 19-525; p = 0.036). In USD, this translates to a mean of nearly USD 21,000 less for prophylactic surgery. Mean direct cost was 41% higher (nearly USD 12,000) in patients with a pathologic fracture (CU, 382 ± 300 versus 227 ± 93; mean difference, 155; 95% CI, 9-300; p = 0.038). Mean length of stay was longer in patients with pathologic fractures compared with the group treated prophylactically (8 ± 6 versus 4 ± 3 days; mean difference, 4; 95% CI, 1-7; p = 0.01)., Conclusions: These findings show economic and clinical value of prophylactic stabilization of metastatic lesions when performed for patients with painful lesions compromising the structural integrity of long bones. Patients sustaining a pathologic fracture may represent a more severe, sicker demographic than patients treated for impending pathologic lesions., Level of Evidence: Level IV, economic and decision analysis.
- Published
- 2016
- Full Text
- View/download PDF
14. CORR(®) Tumor Board: Sacral Insufficiency Fractures are Common After High-dose Radiation for Sacral Chordomas Treated With or Without Surgery.
- Author
-
Anderson ME, Wu JS, and Vargas SO
- Subjects
- Humans, Chordoma radiotherapy, Fractures, Spontaneous etiology, Sacrum radiation effects, Spinal Fractures etiology, Spinal Fractures prevention & control, Spinal Neoplasms radiotherapy
- Published
- 2016
- Full Text
- View/download PDF
15. Sacral Insufficiency Fractures are Common After High-dose Radiation for Sacral Chordomas Treated With or Without Surgery.
- Author
-
Osler P, Bredella MA, Hess KA, Janssen SJ, Park CJ, Chen YL, DeLaney TF, Hornicek FJ, and Schwab JH
- Subjects
- Chordoma surgery, Humans, Radiotherapy Dosage, Retrospective Studies, Risk Factors, Spinal Neoplasms surgery, Chordoma radiotherapy, Fractures, Spontaneous etiology, Sacrum radiation effects, Spinal Fractures etiology, Spinal Fractures prevention & control, Spinal Neoplasms radiotherapy
- Abstract
Background: Surgery with high-dose radiation and high-dose radiation alone for sacral chordomas have shown promising local control rates. However, we have noted frequent sacral insufficiency fractures and perceived this rate to be higher than previously reported., Questions/purposes: We wished (1) to characterize the incidence of sacral insufficiency fractures in patients with chordomas of the sacrum who received high-dose radiation, and (2) to determine whether patients treated with surgery plus high-dose radiation or high-dose radiation alone are more likely to experience a sacral fracture, and to compare time to fracture in these groups., Methods: Sixty-two patients who received high-dose radiation for sacral chordomas with (n = 44) or without surgical resection (n = 18) between 1992 and 2013 were included in this retrospective study. At our institution, sacral chordomas generally are treated by preoperative radiotherapy, followed by en bloc resection, and postoperative radiotherapy. Radiation alone, with an intent to cure, is offered to patients who otherwise are not good surgical candidates or patients who elect radiotherapy based on tumor location and the anticipated morbidity after surgery (such as sexual, bowel, or bladder dysfunction). MRI and CT scans were evaluated for evidence of sacral insufficiency fractures. Complete followup was available at a minimum of 2 years (or until fracture or death) for all 18 patients who underwent radiation alone, whereas 14% (six of 44 patients) in the surgery plus radiation group (9% [three of 33] after high sacrectomy and 27% [three of 11] after low sacrectomy) were lost to followup before 2 years., Results: Sacral insufficiency fractures occurred in 29 of the 62 patients (47%). A total of 25 of 33 patients (76%) with high sacrectomy had fractures develop compared with zero of 11 (0%) after low sacrectomy, and four of the 18 patients (22%) who had high-dose radiation alone (p < 0.001). The fracture rate was greater in the high sacrectomy group than in the low sacrectomy group (p < 0.001) and the radiation only group (p < 0.001). There was no difference with the numbers evaluated in fracture probability between patients in the low-sacrectomy group and those treated with radiation alone (p = 0.112). The fracture-free survival probability was 0.99 for the low sacrectomy group at all times as there were no insufficiency fractures in this group; the 1-year fracture-free survival probability was 0.53 (95% CI, 0.35-0.69) after high sacrectomy, 0.83 (95% CI, 0.57-0.94) after radiation alone; the 2-year fracture-free survival probability was 0.36 (95% CI, 0.19-0.52) after high sacrectomy and 0.77 (95% CI, 0.50-0.91) after radiation alone; and the 5-year fracture-free survival probability was 0.14 (95% CI, 0.04-0.30) after high sacrectomy and 0.77 (95% CI, 0.50-0.91) after radiation alone., Conclusions: Acknowledging the limitations of potential differences in baseline and followup among treatment groups in our study, we found that almost ½ of our patients experienced an insufficiency fracture. We found that the fracture rate was greater in the surgery group compared with the radiation alone group and that high sacrectomy accounted for all fractures in the surgery group. These findings can be used to inform patients and also support the need for further research to elucidate the influence of high-dose radiation on bone quality., Level of Evidence: Level III, therapeutic study.
- Published
- 2016
- Full Text
- View/download PDF
16. CORR Insights(®): Sacral Insufficiency Fractures are Common after High-dose Radiation for Sacral Chordomas Treated With or Without Surgery.
- Author
-
Patt JC
- Subjects
- Humans, Chordoma radiotherapy, Fractures, Spontaneous etiology, Sacrum radiation effects, Spinal Fractures etiology, Spinal Fractures prevention & control, Spinal Neoplasms radiotherapy
- Published
- 2016
- Full Text
- View/download PDF
17. 2015 Marshall Urist Young Investigator Award: Prognostication in Patients With Long Bone Metastases: Does a Boosting Algorithm Improve Survival Estimates?
- Author
-
Janssen SJ, van der Heijden AS, van Dijke M, Ready JE, Raskin KA, Ferrone ML, Hornicek FJ, and Schwab JH
- Subjects
- Bone Neoplasms complications, Female, Fractures, Bone etiology, Fractures, Spontaneous etiology, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Survival Analysis, Algorithms, Awards and Prizes, Bone Neoplasms mortality, Bone Neoplasms secondary, Fractures, Bone mortality, Fractures, Spontaneous mortality, Nomograms
- Abstract
Background: Survival estimation guides surgical decision-making in metastatic bone disease. Traditionally, classic scoring systems, such as the Bauer score, provide survival estimates based on a summary score of prognostic factors. Identification of new factors might improve the accuracy of these models. Additionally, the use of different algorithms--nomograms or boosting algorithms--could further improve accuracy of prognostication relative to classic scoring systems. A nomogram is an extension of a classic scoring system and generates a more-individualized survival probability based on a patient's set of characteristics using a figure. Boosting is a method that automatically trains to classify outcomes by applying classifiers (variables) in a sequential way and subsequently combines them. A boosting algorithm provides survival probabilities based on every possible combination of variables., Questions/purposes: We wished to (1) assess factors independently associated with decreased survival in patients with metastatic long bone fractures and (2) compare the accuracy of a classic scoring system, nomogram, and boosting algorithms in predicting 30-, 90-, and 365-day survival., Methods: We included all 927 patients in our retrospective study who underwent surgery for a metastatic long bone fracture at two institutions between January 1999 and December 2013. We included only the first procedure if patients underwent multiple surgical procedures or had more than one fracture. Median followup was 8 months (interquartile range, 3-25 months); 369 of 412 (90%) patients who where alive at 1 year were still in followup. Multivariable Cox regression analysis was used to identify clinical and laboratory factors independently associated with decreased survival. We created a classic scoring system, nomogram, and boosting algorithms based on identified variables. Accuracy of the algorithms was assessed using area under the curve analysis through fivefold cross validation., Results: The following factors were associated with a decreased likelihood of survival after surgical treatment of a metastatic long bone fracture, after controlling for relevant confounding variables: older age (hazard ratio [HR], 1.0; 95% CI, 1.0-1.0; p < 0.001), additional comorbidity (HR, 1.2; 95% CI, 1.0-1.4; p = 0.034), BMI less than 18.5 kg/m(2) (HR, 2.0; 95% CI, 1.2-3.5; p = 0.011), tumor type with poor prognosis (HR, 1.8; 95% CI, 1.6-2.2; p < 0.001), multiple bone metastases (HR, 1.3; 95% CI, 1.1-1.6; p = 0.008), visceral metastases (HR, 1.6; 95% CI, 1.4-1.9; p < 0.001), and lower hemoglobin level (HR, 0.91; 95% CI, 0.87-0.96; p < 0.001). The survival estimates by the nomogram were moderately accurate for predicting 30-day (area under the curve [AUC], 0.72), 90-day (AUC, 0.75), and 365-day (AUC, 0.73) survival and remained stable after correcting for optimism through fivefold cross validation. Boosting algorithms were better predictors of survival on the training datasets, but decreased to a performance level comparable to the nomogram when applied on testing datasets for 30-day (AUC, 0.69), 90-day (AUC, 0.75), and 365-day (AUC, 0.72) survival prediction. Performance of the classic scoring system was lowest for all prediction periods., Conclusions: Comorbidity status and BMI are newly identified factors associated with decreased survival and should be taken into account when estimating survival. Performance of the boosting algorithms and nomogram were comparable on the testing datasets. However, the nomogram is easier to apply and therefore more useful to aid surgical decision making in clinical practice., Level of Evidence: Level III, prognostic study.
- Published
- 2015
- Full Text
- View/download PDF
18. Are Allogeneic Blood Transfusions Associated With Decreased Survival After Surgery for Long-bone Metastatic Fractures?
- Author
-
Janssen SJ, Braun Y, Ready JE, Raskin KA, Ferrone ML, Hornicek FJ, and Schwab JH
- Subjects
- Aged, Bone Neoplasms complications, Female, Fractures, Spontaneous etiology, Humans, Male, Middle Aged, Retrospective Studies, Survival Rate, Bone Neoplasms secondary, Bone Neoplasms surgery, Fractures, Spontaneous mortality, Fractures, Spontaneous surgery, Transfusion Reaction
- Abstract
Background: Previous studies have shown that perioperative blood transfusion increases cancer recurrence and decreases patient survival after resection of primary malignancies. The question arises whether this association also exists in patients with already disseminated disease undergoing surgery for metastatic long-bone fractures., Purposes: We sought to determine whether perioperative allogeneic blood transfusion is associated with decreased survival after operative treatment of long-bone metastatic fractures after accounting for clinical, laboratory, and treatment factors. Secondarily, we aimed to identify potential factors that are associated with decreased survival., Methods: We included 789 patients in our retrospective study who underwent surgery at two institutions for a pathologic or impending metastatic long-bone fracture. We used multivariable Cox proportional hazards regression model analysis to assess the relationship of perioperative allogeneic blood transfusion with survival, and accounted for patient age, sex, comorbidities, BMI, tumor type, fracture type and location, presence of other bone and visceral metastases, previous radiotherapy and systemic therapy, preoperative embolization, preoperative hemoglobin level, treatment type, anesthesia time, blood loss, duration of hospital admission, year of surgery, and hospital., Results: Considering transfusion as an "exposure," and comparing patients who received transfusions with those who did not, we found that blood transfusion was not associated with decreased survival after accounting for all explanatory variables (hazard ratio [HR] 1.06; 95% CI, 0.87-1.30; p = 0.57). Evaluating transfusion in terms of dose-response, we found that patients who received more transfusions had lower survival compared with those who had fewer transfusions after accounting for all explanatory variables (HR per unit of blood transfused, 1.07; 95% CI, 1.02-1.12; p = 0.005). We found that age (HR, 1.02; 95% CI, 1.01-1.02; p < 0.001), comorbidity status (HR, 1.06; 95% CI, 1.01-1.10; p = 0.014), duration of hospital stay (HR, 1.02; 95% CI 1.00-1.03; p = 0.021), tumor type (HR, 1.71; 95% CI, 1.44-2.03; p < 0.001), and visceral metastases (HR, 1.59; 95% CI, 1.34-1.88; p < 0.001) were independently associated with survival., Conclusion: We found that exposure to perioperative allogeneic blood transfusion does not decrease survival, with the numbers available. However, our sample size might have been insufficient to reveal a small but potentially relevant effect. Our results do suggest a dose-response relationship; patients who received more transfusions had lower survival compared with those with fewer transfusions. Risk of death increased by 7% per unit of blood transfused., Level of Evidence: Level III, prognostic study.
- Published
- 2015
- Full Text
- View/download PDF
19. Is curettage and high-speed burring sufficient treatment for aneurysmal bone cysts?
- Author
-
Wang EH, Marfori ML, Serrano MV, and Rubio DA
- Subjects
- Adolescent, Adult, Argon Plasma Coagulation, Bone Cysts, Aneurysmal complications, Bone Cysts, Aneurysmal diagnosis, Bone Cysts, Aneurysmal pathology, Bone Cysts, Aneurysmal surgery, Bone Transplantation, Child, Cryotherapy methods, Evidence-Based Medicine, Female, Follow-Up Studies, Fractures, Spontaneous etiology, Fractures, Spontaneous prevention & control, Genu Varum etiology, Humans, Male, Middle Aged, Nitrogen administration & dosage, Recurrence, Retrospective Studies, Treatment Outcome, Young Adult, Bone Cysts, Aneurysmal therapy, Curettage adverse effects
- Abstract
Background: To decrease the recurrence rate after intralesional curettage for aneurysmal bone cysts, different adjuvant treatments have been recommended. Liquid nitrogen spray and argon beam coagulation have provided the lowest recurrence rates, but unlike the high-speed burr, these adjuvants are not always available in operating rooms., Questions/purposes: We asked: (1) Is high-speed burring alone sufficient as an adjuvant to curettage with respect to recurrence rates? (2) What is the complication rate from this technique? (3) What are the risk factors for local recurrence?, Methods: A retrospective review of the database of the University Musculoskeletal Tumor Unit and the private files of the senior author (EHW) for a period of 19 years (1993-2011) was performed to identify all patients histologically diagnosed with primary aneurysmal bone cyst. During that period, patients with aneurysmal bone cysts were treated with intralesional curettage, burring, and bone grafting if the lesions showed an adequate cortical wall or a wall with thinned out portions which could be reconstructed with bone grafting. Based on those indications, we treated 54 patients for this condition. Of those, 18 were treated using approaches other than burring because they did not meet the defined indications, and an additional five patients were lost to followup before 2 years, leaving 31 patients for analysis, all of whom were followed up for at least 2 years (mean, 7 years; range, 2-18 years)., Results: Of these 31 patients, one had a recurrence (3.2%). Complications using this approach occurred in three patients (9.7%), and included growth plate deformity (1) and genu varus (2) secondary to collapse of the reconstructed condyle. With only one recurrence, we cannot answer what the risk factors might be for recurrence; however, the one patient with recurrence presented with a large lesion and a pathologic fracture., Conclusions: Curettage, burring, and bone grafting compare favorably in the literature with other approaches for aneurysmal bone cysts, such as cryotherapy and argon-beam coagulation. We conclude that high-speed burring alone as an adjuvant to intralesional curettage is a reasonable approach to achieving a low recurrence rate for aneurysmal bone cysts., Level of Evidence: Level IV, therapeutic study. See the Instructions for Authors for a complete description of levels of evidence.
- Published
- 2014
- Full Text
- View/download PDF
20. Does fracture affect the healing time or frequency of recurrence in a simple bone cyst of the proximal femur?
- Author
-
Cha SM, Shin HD, Kim KC, and Park JW
- Subjects
- Adolescent, Bone Cysts complications, Bone Cysts diagnosis, Bone Nails, Child, Female, Femoral Fractures diagnosis, Femoral Fractures etiology, Fractures, Spontaneous diagnosis, Fractures, Spontaneous etiology, Humans, Male, Prosthesis Design, Recurrence, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Bone Cysts surgery, Femoral Fractures surgery, Fracture Fixation, Intramedullary adverse effects, Fracture Fixation, Intramedullary instrumentation, Fracture Healing, Fractures, Spontaneous surgery
- Abstract
Background: Studies have focused on intramedullary nailing of femoral simple bone cysts but have not clarified the recurrence frequency or management of recurrent cysts. In particular, the affect of pathologic fractures on cyst healing, recurrence, and complications of treatment have not been reported., Questions/purposes: We performed a retrospective comparative study to examine whether there were differences between simple bone cysts in the proximal femur nailed after pathologic fracture and those without pathologic fracture in terms of (1) healing time, (2) frequency and timing of recurrence, and (3) complications., Methods: From 1995 to 2005, 54 patients diagnosed with femoral simple bone cysts were treated and followed for a minimum of 8 years. Flexible nails were inserted in a retrograde fashion in 25 patients with fractures and 29 patients without fractures. The healing period, degree of radiographic consolidation based on the criteria of Capanna et al., recurrence frequency, and final bony abnormalities were analyzed. The mean followups were 107 months (range, 96-124 months) and 103 months (range, 96-140 months) in the groups with and without fractures, respectively. With the numbers available, a post hoc calculation showed that this study had 80% power to detect a difference of 7 months of healing time as significant with a probability less than 0.05., Results: With the numbers available, the mean healing period was not different between groups (25 versus 30 months in the groups with and without fractures, respectively; p = 0.16). Complete healing was observed at 19 versus 18 months, incomplete healing at 5 versus 8 months, and recurrence was observed in one and three patients in the groups with and without fractures, respectively. No differences were found in the distribution of healing grade based on the criteria of Capanna et al. A second surgery was performed using intramedullary nails in two patients with an open physis and compression hip screw fixation was performed in two patients with a closed physis. Finally, the recurrent cysts were classified as completely healed in three patients and incompletely healed in one., Conclusions: Whether a pathologic fracture had occurred before surgical treatment, intramedullary nailing of femoral simple bone cysts resulted in reliable healing, and the frequency of recurrence did not differ. Because this was a retrospective study, the optimal treatment for recurred cysts after intramedullary nailing should be further investigated through a comparative or prospective study.
- Published
- 2014
- Full Text
- View/download PDF
21. Giant cell tumor with pathologic fracture: should we curette or resect?
- Author
-
van der Heijden L, Dijkstra PD, Campanacci DA, Gibbons CL, and van de Sande MA
- Subjects
- Adolescent, Adult, Aged, Bone Neoplasms complications, Bone Neoplasms mortality, Bone Neoplasms pathology, Child, Disease-Free Survival, Europe, Female, Fracture Fixation, Fracture Healing, Fractures, Spontaneous etiology, Fractures, Spontaneous mortality, Fractures, Spontaneous pathology, Giant Cell Tumor of Bone complications, Giant Cell Tumor of Bone mortality, Giant Cell Tumor of Bone pathology, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Recurrence, Local, Proportional Hazards Models, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Young Adult, Bone Neoplasms surgery, Curettage adverse effects, Curettage mortality, Fractures, Spontaneous surgery, Giant Cell Tumor of Bone surgery, Osteotomy adverse effects, Osteotomy mortality, Plastic Surgery Procedures adverse effects, Plastic Surgery Procedures mortality
- Abstract
Background: Approximately one in five patients with giant cell tumor of bone presents with a pathologic fracture. However, recurrence rates after resection or curettage differ substantially in the literature and it is unclear when curettage is reasonable after fracture., Questions/purposes: We therefore determined: (1) local recurrence rates after curettage with adjuvants or en bloc resection; (2) complication rates after both surgical techniques and whether fracture healing occurred after curettage with adjuvants; and (3) function after both treatment modalities for giant cell tumor of bone with a pathologic fracture., Methods: We retrospectively reviewed 48 patients with fracture from among 422 patients treated between 1981 and 2009. The primary treatment was resection in 25 and curettage with adjuvants in 23 patients. Minimum followup was 27 months (mean, 101 months; range, 27-293 months)., Results: Recurrence rate was higher after curettage with adjuvants when compared with resection (30% versus 0%). Recurrence risk appears higher with soft tissue extension. The complication rate was lower after curettage with adjuvants when compared with resection (4% versus 16%) and included aseptic loosening of prosthesis, allograft failure, and pseudoarthrosis. Tumor and fracture characteristics did not increase complication risk. Fracture healing occurred in 24 of 25 patients. Mean Musculoskeletal Tumor Society score was higher after curettage with adjuvants (mean, 28; range, 23-30; n = 18) when compared with resection (mean, 25; range, 13-30; n = 25)., Conclusions: Our observations suggest curettage with adjuvants is a reasonable option for giant cell tumor of bone with pathologic fractures. Resection should be considered with soft tissue extension, fracture through a local recurrence, or when structural integrity cannot be regained after reconstruction., Level of Evidence: Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
- Published
- 2013
- Full Text
- View/download PDF
22. Prophylactic stabilization for bone metastases, myeloma, or lymphoma: do we need to protect the entire bone?
- Author
-
Alvi HM and Damron TA
- Subjects
- Adult, Aged, Aged, 80 and over, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Bone Neoplasms complications, Bone Neoplasms diagnostic imaging, Bone Neoplasms mortality, Bone Neoplasms secondary, Disease Progression, Embolism etiology, Embolism surgery, Female, Femoral Fractures diagnostic imaging, Femoral Fractures etiology, Femoral Fractures mortality, Femoral Neoplasms complications, Femoral Neoplasms secondary, Femoral Neoplasms surgery, Fractures, Spontaneous diagnostic imaging, Fractures, Spontaneous etiology, Fractures, Spontaneous mortality, Hemiarthroplasty, Humans, Humeral Fractures diagnostic imaging, Humeral Fractures etiology, Humeral Fractures mortality, Internal Fixators, Lymphoma mortality, Male, Middle Aged, Multiple Myeloma mortality, Radiography, Reoperation, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Arthroplasty adverse effects, Arthroplasty instrumentation, Arthroplasty mortality, Bone Neoplasms surgery, Femoral Fractures prevention & control, Fracture Fixation, Internal adverse effects, Fracture Fixation, Internal instrumentation, Fracture Fixation, Internal mortality, Fractures, Spontaneous prevention & control, Humeral Fractures prevention & control, Lymphoma pathology, Multiple Myeloma secondary
- Abstract
Background: The current operative standard of care for disseminated malignant bone disease suggests stabilizing the entire bone to avoid the need for subsequent operative intervention but risks of doing so include complications related to embolic phenomena., Questions/purposes: We questioned whether progression and reoperation occur with enough frequency to justify additional risks of longer intramedullary devices., Methods: A retrospective chart review was done for 96 patients with metastases, myeloma, or lymphoma who had undergone stabilization or arthroplasty of impending or actual femoral or humeral pathologic fractures using an approach favoring intramedullary fixation devices and long-stem arthroplasty. Incidence of progressive bone disease, reoperation, and complications associated with fixation and arthroplasty devices in instrumented femurs or humeri was determined., Results: At minimum 0 months followup (mean, 11 months; range, 0-72 months), 80% of patients had died. Eleven of 96 patients (12%) experienced local bony disease progression; eight had local progression at the original site, two had progression at originally recognized discretely separate lesions, and one had a new lesion develop in the bone that originally was surgically treated. Six subjects (6.3%) required repeat operative intervention for symptomatic failure. Twelve (12.5%) patients experienced physiologic nonfatal complications potentially attributable to embolic phenomena from long intramedullary implants., Conclusions: Because most patients in this series were treated with the intent to protect the bone with long intramedullary implants when possible, the reoperation rate may be lower than if the entire bone had not been protected. However, the low incidence of disease progression apart from originally identified lesions (one of 96) was considerably lower than the physiologic complication rate (12 of 96) potentially attributable to long intramedullary implants., Level of Evidence: Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
- Published
- 2013
- Full Text
- View/download PDF
23. Which implant is best after failed treatment for pathologic femur fractures?
- Author
-
Forsberg JA, Wedin R, and Bauer H
- Subjects
- Aged, Arthroplasty, Replacement, Hip adverse effects, Arthroplasty, Replacement, Hip mortality, Chi-Square Distribution, Disease Progression, Female, Femoral Fractures etiology, Femoral Fractures mortality, Femoral Neoplasms complications, Femoral Neoplasms mortality, Femoral Neoplasms secondary, Fracture Fixation, Internal adverse effects, Fracture Fixation, Internal mortality, Fractures, Spontaneous etiology, Fractures, Spontaneous mortality, Humans, Kaplan-Meier Estimate, Limb Salvage, Logistic Models, Male, Middle Aged, Prospective Studies, Prosthesis Design, Registries, Reoperation, Time Factors, Treatment Failure, Arthroplasty, Replacement, Hip instrumentation, Femoral Fractures surgery, Femoral Neoplasms surgery, Fracture Fixation, Internal instrumentation, Fractures, Spontaneous surgery, Hip Prosthesis, Internal Fixators
- Abstract
Background: Successful treatment of pathologic femur fractures can preserve a patient's independence and quality of life. The choice of implant depends on several disease- and patient-specific variables; however, its durability must generally match the patient's estimated life expectancy. Failures do occur, however, it is unclear which implants are associated with greater risk of failure., Questions/purposes: We evaluated patients with femoral metastases in whom implants failed to determine (1) the rate of reoperation; (2) the timing of and most common causes for failure; and (3) incidence of perioperative complications and death., Methods: From a prospectively collected registry, we identified 93 patients operated on for failed treatment of femoral metastases from 1990 to 2010. We excluded five patients who subsequently underwent amputations leaving 88 who underwent salvage procedures. These included intramedullary nails (n = 11), endoprostheses (n = 61), and plate fixation (n = 16). The primary outcome was reoperation after salvage treatment., Results: Seventeen of the 88 patients (19%) required subsequent reoperation a median of 10 months (interquartile range, 4-14) from the time of salvage surgery: 15 for material failure, one for local progression of tumor, and one for a combination of these. Five patients died within 4 weeks of surgery. Although perioperative complications were higher in the endoprosthesis group and dislocations occurred, overall treatment failures after salvage surgery were lower in the that group (four of 61) compared the group with plate fixation (eight of 16) and intramedullary nail groups (five of 11)., Conclusions: Despite relatively common perioperative complications, salvage using endoprostheses may be associated with fewer treatment failures as compared with internal fixation., Level of Evidence: Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
- Published
- 2013
- Full Text
- View/download PDF
24. Endoprostheses last longer than intramedullary devices in proximal femur metastases.
- Author
-
Harvey N, Ahlmann ER, Allison DC, Wang L, and Menendez LR
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Bone Nails, Breast Neoplasms pathology, Female, Femoral Fractures etiology, Femoral Neoplasms secondary, Fractures, Spontaneous etiology, Fractures, Spontaneous surgery, Humans, Kidney Neoplasms pathology, Lung Neoplasms pathology, Male, Middle Aged, Prosthesis Failure, Prosthesis Implantation, Prosthesis-Related Infections epidemiology, Plastic Surgery Procedures methods, Retrospective Studies, Sarcoma secondary, Young Adult, Femoral Fractures surgery, Femoral Neoplasms complications, Fracture Fixation, Internal methods, Prostheses and Implants
- Abstract
Background: The proximal femur is the most common site of surgery for bone metastases, and stabilization may be achieved through intramedullary fixation (IMN) or endoprosthetic reconstruction (EPR). Intramedullary devices are less expensive, less invasive, and may yield improved function over endoprostheses. However, it is unclear which, if either, has any advantages., Questions/purposes: We determined whether function, complications, and survivorship differed between the two approaches., Methods: We retrospectively reviewed 158 patients with 159 proximal femur metastatic lesions treated with surgical stabilization. Forty-six were stabilized with IMN and 113 were treated with EPR. The minimum followup was 0.25 months (mean, 16 months; median, 17 months; range, 0.25-86 months)., Results: The mean Musculoskeletal Tumor Society score was 24 of 30 (80%) after IMN and 21 of 30 (70%) after EPR. There were 12 complications (26%) in the IMN group, including 10 nonunions, six of which went on to mechanical failure. There were complications in 20 of 113 (18%) of the EPR group, which consisted of 10 dislocations (9%) and 10 infections (9%). There were no mechanical failures with EPR. Both implants remained functional for the limited lifespan of these patients in each group at all time intervals. EPRs were associated with increased implant longevity compared with IMNs (100% versus 85% 5-year survival, respectively) and a decreased rate of mechanical failure (0% versus 11%, respectively) when compared with the intramedullary devices., Conclusions: Patients with metastatic disease to the proximal femur may live for long periods of time, and these patients may undergo stabilization with either IMN or EPR with comparable functional scores and the implant survivorship exceeding patient survivorship at all time intervals. Endoprostheses demonstrate a lower mechanical failure rate and a higher rate of implant survivorship without mechanical failure than IMN devices., Level of Evidence: Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
- Published
- 2012
- Full Text
- View/download PDF
25. Endoprosthetic treatment is more durable for pathologic proximal femur fractures.
- Author
-
Steensma M, Boland PJ, Morris CD, Athanasian E, and Healey JH
- Subjects
- Bone Neoplasms secondary, Breast Neoplasms pathology, Female, Femoral Fractures etiology, Fracture Fixation, Internal, Fracture Fixation, Intramedullary, Fractures, Spontaneous etiology, Humans, Kaplan-Meier Estimate, Lung Neoplasms pathology, Male, Middle Aged, Prostatic Neoplasms pathology, Plastic Surgery Procedures, Reoperation, Retrospective Studies, Treatment Outcome, Bone Neoplasms complications, Femoral Fractures surgery, Fracture Fixation methods, Fractures, Spontaneous surgery, Prostheses and Implants
- Abstract
Background: Pathologic proximal femur fractures result in substantial morbidity for patients with skeletal metastases. Surgical treatment is widely regarded as effective; however, failure rates associated with the most commonly used operative treatments are not well defined., Questions/purposes: We therefore compared surgical treatment failure rates among intramedullary nailing, endoprosthetic reconstruction, and open reduction-internal fixation when applied to impending or displaced pathologic proximal femur fractures., Patients and Methods: We retrospectively compared the clinical course of 298 patients who underwent intramedullary nailing (n = 82), endoprosthetic reconstruction (n = 197), or open reduction-internal fixation (n = 19) from 1993 to 2008. Primary outcome was treatment failure, which was defined as reoperation for any reason. Treatment groups were compared for differences in demographic and clinical parameters., Results: The number of treatment failures in the endoprosthetic reconstruction group (3.1%) was significantly lower than in the intramedullary nailing (6.1%) and open reduction-internal fixation (42.1%) groups. The number of revisions requiring implant exchange also was significantly lower for endoprosthetic reconstruction (0.5%), compared with intramedullary nailing (6.1%) and open reduction-internal fixation (42.1%)., Conclusions: Endoprosthetic reconstruction is associated with fewer treatment failures and greater implant durability. Prospective studies are needed to determine the impact of operative strategy on function and quality of life., Level of Evidence: Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
- Published
- 2012
- Full Text
- View/download PDF
26. Letter to the editor: Unexplained fractures: child abuse or bone disease: a systematic review.
- Author
-
Karst WA and van Rijn RR
- Subjects
- Bone Diseases complications, Child, Evidence-Based Medicine, Fractures, Bone etiology, Fractures, Spontaneous diagnosis, Fractures, Spontaneous etiology, Humans, Osteogenesis Imperfecta complications, Osteogenesis Imperfecta diagnosis, Risk Assessment, Risk Factors, Bone Diseases diagnosis, Child Abuse diagnosis, Crime Victims, Fractures, Bone diagnosis
- Published
- 2011
- Full Text
- View/download PDF
27. Gender differences in osteoporosis and fractures.
- Author
-
Cawthon PM
- Subjects
- Bone Density physiology, Female, Fractures, Spontaneous epidemiology, Fractures, Spontaneous prevention & control, Humans, Male, Mass Screening, Men, Osteoporosis diagnosis, Osteoporosis epidemiology, Osteoporosis therapy, Risk Factors, Sex Factors, Treatment Outcome, Women, Women's Health, Fractures, Spontaneous etiology, Health Services Accessibility, Healthcare Disparities, Osteoporosis complications, Prejudice, Sex Characteristics
- Abstract
Background: Osteoporosis is generally thought of as a "woman's disease" because the prevalence of osteoporosis and the rate of fractures are much higher in postmenopausal women than in older men. However, the absolute number of men affected by osteoporosis and fractures is large, as at least 2.8 million men in the United States are thought to have osteoporosis., Questions/purposes: The purposes of this review are to (1) highlight gender differences in osteoporosis and fracture risk, (2) describe disparities in treatment and outcomes after fractures between men and women, and (3) propose solutions to reducing disparities in treatment and prevention., Methods: A literature survey was conducted using MEDLINE with a variety of search terms and using references from the author's personal collection of articles. A formal search strategy and exclusion criteria were not employed and the review is therefore selective. WHERE ARE WE NOW?: Postmenopausal women have a higher prevalence of osteoporosis and greater incidence of fracture than older men. Despite the higher fracture risk in postmenopausal women, older men tend to have worse outcomes after fracture and poorer treatment rates, although less is known about the disease course in men. Multifaceted interventions to improve the screening and treatment for osteoporosis were recently developed. WHERE DO WE NEED TO GO?: Improvement in treatment rates of those at risk, regardless of gender, is an important goal in osteoporosis management. HOW DO WE GET THERE?: Further development and evaluation of cost-effective, multifaceted interventions for screening and treatment of osteoporosis and fractures are needed; such interventions will likely improve the primary prevention of fractures.
- Published
- 2011
- Full Text
- View/download PDF
28. Unexplained fractures: child abuse or bone disease? A systematic review.
- Author
-
Pandya NK, Baldwin K, Kamath AF, Wenger DR, and Hosalkar HS
- Subjects
- Bone Diseases complications, Child, Child, Preschool, Diagnosis, Differential, Fractures, Bone etiology, Fractures, Spontaneous diagnosis, Fractures, Spontaneous etiology, Humans, Infant, Osteogenesis Imperfecta complications, Osteogenesis Imperfecta diagnosis, Bone Diseases diagnosis, Child Abuse diagnosis, Crime Victims, Fractures, Bone diagnosis
- Abstract
Background: Child abuse and neglect (CAN) is a serious problem that has major implications for the welfare of the child involved. Unexplained fractures are of particular concern to the orthopaedic surgeon, who must often consider alternative diagnoses to CAN., Questions/purposes: We therefore (1) determined which bone diseases most commonly mimic CAN; (2) what types of osteogenesis imperfecta (OI) are most commonly confused with CAN and why; and (3) what specific findings in OI and bone disease render a mistaken diagnosis of CAN more likely., Methods: A systematic review of the literature was performed. We identified studies that compared cases of CAN with cases in which patients had bone disease that resulted in an unexplained fracture. We also included studies in which patients with fractures resulting from underlying bony pathology were misclassified as CAN and were subsequently reclassified as bone disease as a result of further investigation. Our search netted only five studies that directly compared and contrasted CAN with metabolic or genetic bone disease in the same study., Results: The published literature suggests OI is most frequently confused with CAN, although metaphyseal dysplasia, disorders of phosphate metabolism, and temporary brittle bone disease are also documented in the literature identified by our search. Difficulty in differentiating these bony diseases from CAN stems from ambiguity in the history and physical examination at the time of presentation., Conclusions: Bone disease is a diagnosis of exclusion in the differential diagnosis of CAN.
- Published
- 2011
- Full Text
- View/download PDF
29. Gender-specific Issues in Orthopaedic Surgery: Editorial Comment.
- Author
-
Rozental TD
- Subjects
- Female, Fractures, Spontaneous etiology, Fractures, Spontaneous surgery, Humans, Male, Osteoarthritis complications, Osteoarthritis surgery, Osteoporosis complications, Osteoporosis surgery, Sex Factors, Fractures, Spontaneous physiopathology, Men's Health, Orthopedic Procedures, Osteoarthritis physiopathology, Osteoporosis physiopathology, Women's Health
- Published
- 2010
- Full Text
- View/download PDF
30. Results of a minimally invasive technique for treatment of unicameral bone cysts.
- Author
-
Mik G, Arkader A, Manteghi A, and Dormans JP
- Subjects
- Adolescent, Bone Cysts complications, Child, Cohort Studies, Decompression, Surgical methods, Female, Femur diagnostic imaging, Femur surgery, Follow-Up Studies, Fracture Fixation methods, Fracture Healing physiology, Fractures, Spontaneous diagnostic imaging, Fractures, Spontaneous etiology, Humans, Humerus diagnostic imaging, Humerus surgery, Infant, Male, Probability, Prognosis, Radiography, Radius diagnostic imaging, Radius surgery, Risk Assessment, Tibia diagnostic imaging, Tibia surgery, Treatment Outcome, Bone Cysts diagnostic imaging, Bone Cysts surgery, Fractures, Spontaneous surgery, Orthopedic Procedures methods
- Abstract
Unlabelled: Unicameral bone cysts are benign bone lesions commonly seen in pediatric patients. Several treatment methods have been described with variable results and high recurrence rates. We previously reported short-term success of a minimally invasive technique that includes combining percutaneous decompression and grafting with medical-grade calcium sulfate pellets. The purpose of this study was to review the additional long-term results with a minimum followup of 24 months (average, 37 months; range, 24-70 months). We identified 55 patients with an average age of 10.8 years (range, 1.3-18 years). Forty-one of 55 lesions occurred in the humerus and femur. Forty-four of 55 (80%) patients had a partial or complete response after initial surgery; of these, seven obtained a partial or complete response after a repeat surgery (cumulative healing rate, 94%). Two patients underwent a third surgery (cumulative healing rate, 98%). One underwent a third repeat surgery (cumulative healing rate, 100%). There were no major complications associated with the procedure. Two patients had a superficial infection that resolved with oral antibiotics. Although some patients required a repeat procedure, complete or partial response at a minimum 24 months' followup was achieved in all patients., Level of Evidence: Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
- Published
- 2009
- Full Text
- View/download PDF
31. Consequences and prevention of inadvertent internal fixation of primary osseous sarcomas.
- Author
-
Adams SC, Potter BK, Mahmood Z, Pitcher JD, and Temple HT
- Subjects
- Aged, Bone Neoplasms complications, Bone Neoplasms mortality, Female, Fluoroscopy, Fracture Fixation, Internal, Fractures, Spontaneous diagnostic imaging, Fractures, Spontaneous etiology, Fractures, Spontaneous surgery, Humans, Limb Salvage, Male, Middle Aged, Retrospective Studies, Sarcoma complications, Sarcoma mortality, Survival Analysis, Bone Neoplasms surgery, Sarcoma surgery
- Abstract
Unlabelled: The evaluation and treatment of aggressive bone tumors continue to be diagnostic and therapeutic challenges for orthopaedic surgeons. Despite compelling data regarding the hazards of biopsy, incomplete preoperative evaluation, inappropriate biopsy techniques, and premature surgical interventions continue to compromise optimal treatment of primary bone sarcomas. We retrospectively identified eight patients who had internal fixation of a primary bone sarcoma before referral to an orthopaedic oncology service. Six of the eight patients subsequently underwent amputations and two patients underwent limb salvage for local disease control. Biopsy techniques from referring institutions were highly variable, with only two of seven rendering an accurate diagnosis. The average Musculoskeletal Tumor Society functional score was 10.6 and four of eight patients were disease-free and alive at a minimum followup of 8 months (mean, 26.9 months; range, 8-80 months). Implant violation of primary bone malignancies was associated with frequent high-level amputation for local disease control and low Musculoskeletal Tumor Society functional scores. Common errors in the initial evaluation and treatment included inadequate attention to patient history, incomplete radiographic evaluation, and improper biopsy and surgical techniques, which violated compartmental boundaries., Level of Evidence: Level IV, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.
- Published
- 2009
- Full Text
- View/download PDF
32. Sequential changes of bone metabolism in normal and delayed union of the spine.
- Author
-
Ohishi T, Takahashi M, Yamanashi A, Suzuki D, and Nagano A
- Subjects
- Aged, Aged, 80 and over, Biomarkers metabolism, Female, Humans, Magnetic Resonance Imaging, Male, Osteocalcin metabolism, Osteoporosis metabolism, Osteoporosis pathology, Prognosis, Fracture Healing, Fractures, Compression etiology, Fractures, Compression metabolism, Fractures, Compression pathology, Fractures, Spontaneous etiology, Fractures, Spontaneous metabolism, Fractures, Spontaneous pathology, Osteoporosis complications, Spinal Fractures etiology, Spinal Fractures metabolism, Spinal Fractures pathology
- Abstract
Unlabelled: Time-dependent changes in bone markers in delayed or nonunion of vertebral fracture were compared with those of normal union. Thirty-three patients with a fresh vertebral fracture were enrolled. Urinary Type I collagen C-terminal telopeptide, pyridinoline, deoxypyridinoline, serum C-terminal telopeptide, and N-midportion of osteocalcin (OC(N-mid)) were determined at the time of hospital admission (within 24 hours after the fracture event in all cases) and at 2, 4, 12, 24, and 48 weeks thereafter. Subjects were divided into two groups according to the results of MR images taken 48 weeks after fracture. Twenty-four were normally united (Group N) and nine had delayed or nonunion (Group D) of the spine. No differences between values of bone resorption markers in Group N and Group D were observed at any time. Serum OC(N-mid) in Group N started to increase at 2 weeks and reached the peak value at 24 weeks (180%); however, serum OC(N-mid) in Group D increased at most 120% from baseline to 4 weeks. Values of serum OC(N-mid) in Group N were higher at 24 and 48 weeks than those in Group D. Impairment of fracture healing was strongly associated with a deficit in the increase of osteocalcin in the later stage of fracture repair., Level of Evidence: Level II, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.
- Published
- 2008
- Full Text
- View/download PDF
33. Bone graft for large bone cysts of the femoral neck in patients on hemodialysis.
- Author
-
Fukunishi S, Yoh K, and Yoshiya S
- Subjects
- Adult, Bone Cysts complications, Comorbidity, Female, Femur Neck, Fractures, Spontaneous etiology, Fractures, Spontaneous prevention & control, Hip Joint physiopathology, Humans, Kidney Failure, Chronic therapy, Male, Middle Aged, Range of Motion, Articular, Renal Dialysis adverse effects, Retrospective Studies, Bone Cysts epidemiology, Bone Cysts surgery, Bone Transplantation, Ilium transplantation, Kidney Failure, Chronic epidemiology
- Abstract
Pathologic fracture of the femoral neck from an amyloid bone cyst in patients on long-term hemodialysis causes substantial morbidity. For patients with a bone cyst occupying more than 1/2 of the neck width, we have performed prophylactic internal fixation with an autogenous iliac bone graft. We describe our surgical technique and present clinical results from consecutively surgically treated patients. We determined whether our procedure successfully induced healing of the bone cyst, thus preventing a problematic sequel of fracture. From 1990 to 2003, 14 hips in 12 patients were treated, and the clinical results from these patients were retrospectively reviewed. One patient died 3 months after surgery; the remaining patients were followed for at least 3 years. In those 11 patients, bony healing was achieved in all cases with no recurrence of the cystic lesion. Considering the comparatively unsatisfactory results of internal fixation for pathologic fracture and THA for patients receiving long-term hemodialysis, our procedure gives surgeons another option for treating this difficult problem.
- Published
- 2007
- Full Text
- View/download PDF
34. Is there an indication for prophylactic balloon kyphoplasty? A pilot study.
- Author
-
Becker S, Garoscio M, Meissner J, Tuschel A, and Ogon M
- Subjects
- Aged, Bone Cements therapeutic use, Female, Fractures, Spontaneous etiology, Fractures, Spontaneous therapy, Health Status, Humans, Male, Osteoporosis complications, Postoperative Complications, Prospective Studies, Radiography, Secondary Prevention, Spinal Fractures etiology, Spinal Fractures therapy, Treatment Outcome, Catheterization, Fractures, Spontaneous prevention & control, Orthopedic Procedures, Spinal Fractures prevention & control
- Abstract
Vertebroplasty and kyphoplasty are associated with a recurrent fracture rate of 2.4% to 23%, which is lower than the general natural history of untreated osteoporotic fractures. Some authors suggest the risk of refracture at adjacent vertebra will be reduced by prophylactic stabilization. We therefore compared the refracture rate after prophylactic balloon kyphoplasty in 60 patients randomized into groups with either monosegmental balloon kyphoplasty or adjacent prophylactic balloon kyphoplasty. The level (superior versus inferior) for prophylactic stabilization was chosen according to fracture type. We evaluated patients for 12 months using radiographs, visual analog scale scores, and SF-36 scores. We followed 23 of 30 patients in the monosegmental group and 27 of 30 patients in the prophylactic group. We observed no difference in the 1-year refracture rates between the two groups (five patients in the monosegmental group and seven in the prophylactic group). Leakage into the disc was the presumed cause of adjacent fractures in 50% of the patients. Disc leakage and refracture rate did not correlate as a result of the low patient number. Based on our data, we believe there is no indication for prophylactic stabilization of adjacent segments with balloon kyphoplasty.
- Published
- 2007
- Full Text
- View/download PDF
35. Case reports: pathologic fracture of the patella from a gouty tophus.
- Author
-
Price MD, Padera RF, Harris MB, and Vrahas MS
- Subjects
- Fractures, Spontaneous surgery, Gout pathology, Humans, Knee Joint diagnostic imaging, Male, Middle Aged, Patella diagnostic imaging, Radiography, Range of Motion, Articular, Fractures, Spontaneous etiology, Gout complications, Patella injuries
- Abstract
Fracture of the patella is a relatively common condition seen in patients with trauma. We report one patient with known gout who sustained relatively minor trauma that resulted in a patellar fracture. An intraoperative biopsy confirmed that much of the patella had been replaced with gouty tophus. Gout is a rare cause of patellar fracture, with few documented cases. Postoperative management of patients with patella fractures secondary to gout may be routine with the addition of medical management for the underlying pathologic process.
- Published
- 2006
- Full Text
- View/download PDF
36. Unipedicle percutaneous vertebroplasty for spinal intraosseous vacuum cleft.
- Author
-
Chen LH, Lai PL, and Chen WJ
- Subjects
- Aged, Aged, 80 and over, Female, Fractures, Spontaneous etiology, Humans, Male, Middle Aged, Monitoring, Intraoperative, Pain Measurement, Polymethyl Methacrylate, Retrospective Studies, Spinal Fractures etiology, Treatment Outcome, Fractures, Spontaneous surgery, Osteoporosis complications, Spinal Fractures surgery
- Abstract
Unlabelled: Osteoporotic compression fractures have been widely treated by vertebroplasty through a bipedicle approach. We suspected that a compression fracture with vacuum cleft can be treated successfully with a unipedicle approach. We retrospectively reviewed 27 patients with an osteoporotic compression fracture with intraosseous vacuum cleft. The patients received percutaneous vertebroplasty with bone cement (polymethylmethacrylate) augmentation. Bone cement was injected into the fractured vertebral body through only one cannula in the selected pedicle. Cement filling, vertebral height restoration, and relief of pain were evaluated. The minimum followup was 12 months (range, 12-30 months). Twenty six of 27 patients had adequate filling. Average vertebral height restoration was 27%. The patients' visual analog scale improved an average of 40 points. Percutaneous transpedicle vertebroplasty is effective for treating osteoporotic compression fractures with intraosseous vacuum clefts. Because of the preexistent cleft, the procedure can be done successfully via a unipedicle approach., Level of Evidence: Therapeutic study, Level IV (case series--no, or historical, control group). See the Guidelines for Authors for a complete description of levels of evidence.
- Published
- 2005
- Full Text
- View/download PDF
37. Fractures of the distal humerus in the elderly: is internal fixation the treatment of choice?
- Author
-
Srinivasan K, Agarwal M, Matthews SJ, and Giannoudis PV
- Subjects
- Aged, Aged, 80 and over, Bone Nails, Bone Plates, Cohort Studies, Elbow Joint physiopathology, Elbow Joint surgery, Female, Follow-Up Studies, Fracture Fixation, Internal instrumentation, Fractures, Spontaneous etiology, Geriatric Assessment, Humans, Humeral Fractures etiology, Male, Middle Aged, Osteoporosis complications, Osteoporosis diagnosis, Pain Measurement, Radiography, Range of Motion, Articular physiology, Recovery of Function, Retrospective Studies, Risk Assessment, Treatment Outcome, Fracture Fixation, Internal methods, Fractures, Spontaneous diagnostic imaging, Fractures, Spontaneous surgery, Humeral Fractures diagnostic imaging, Humeral Fractures surgery
- Abstract
The incidence of osteoporotic fractures of the distal humerus is increasing, and the treatment of these injuries merits closer review. We assessed the results of 28 elderly patients (29 fractures) with a mean age of 85 years (range, 75-100 years). Open reduction and internal fixation was done on 21 elbows, and eight elbows were treated nonoperatively. Orthopaedic Trauma Association grading showed that the group treated with internal fixation had favorable results (three excellent, nine good, seven fair, and two poor) compared with the nonoperatively treated group (zero excellent, two good, three fair, and three poor). Mean loss of extension and mean flexion were better in the surgically treated patients (23.5 degrees and 99 degrees ) than in the nonoperatively treated patients (33.5 degrees and 71 degrees ). Substantial pain relief (mild or no pain) was achieved in a higher proportion (52%) in the surgically treated group than in the nonoperatively treated group (25%). Anatomic restoration of distal humeral tilt and articular congruity also were better in the surgically treated patients. Rates of complications were observed to be comparable to those described in the literature for younger patients. These findings reflect the relevance of surgical fixation of such fractures in this age group highlighting the need for additional clinical studies.
- Published
- 2005
- Full Text
- View/download PDF
38. Pediatric foot fractures.
- Author
-
Ribbans WJ, Natarajan R, and Alavala S
- Subjects
- Adolescent, Ankle, Calcaneus injuries, Child, Female, Fractures, Spontaneous diagnosis, Fractures, Spontaneous etiology, Fractures, Spontaneous therapy, Fractures, Stress diagnosis, Fractures, Stress therapy, Humans, Male, Metatarsal Bones injuries, Orthopedics methods, Osteochondritis complications, Pediatrics methods, Sesamoid Bones injuries, Talus injuries, Tarsal Bones injuries, Toes injuries, Foot Injuries diagnosis, Foot Injuries therapy, Fractures, Bone diagnosis, Fractures, Bone therapy
- Abstract
Fractures of the foot in children usually have a good prognosis and generally are treated nonoperatively. Displaced fractures of the talus and calcaneus and tarsometatarsal dislocations are rare in children and their outcome is generally good in the younger child. Older adolescents with these injuries need treatment similar to how an adult would be treated for the same injury in order to achieve a good result. Foot fractures in children may pose a diagnostic challenge particularly in the absence of obvious radiographic changes. Repeated clinical examination and judicious use of imaging techniques such as isotope bone scans and magnetic resonance imaging are needed to establish a diagnosis. Knowledge of the anatomy and significance of accessory bones of the foot and disorders of the growing foot skeleton are helpful in managing injuries of child's foot. In this study, we review common injuries of a child's foot and include a discussion on differential diagnosis.
- Published
- 2005
- Full Text
- View/download PDF
39. Intra-articular traumatic disorders of the knee in children and adolescents.
- Author
-
Vaquero J, Vidal C, and Cubillo A
- Subjects
- Adolescent, Anterior Cruciate Ligament surgery, Anterior Cruciate Ligament Injuries, Athletic Injuries diagnosis, Athletic Injuries therapy, Child, Female, Fractures, Spontaneous diagnosis, Fractures, Spontaneous etiology, Fractures, Spontaneous therapy, Humans, Knee Injuries classification, Knee Joint surgery, Male, Menisci, Tibial surgery, Orthopedics methods, Osteochondritis complications, Pediatrics methods, Tibial Meniscus Injuries, Knee Injuries diagnosis, Knee Injuries therapy
- Abstract
Intra-articular knee injuries in children traditionally have been considered rarer than injuries in adults. Few studies establish the prevalence of knee injuries before skeletal maturity, but arthroscopic studies suggest an increased frequency of anterior cruciate ligament ruptures, meniscal tears, and osteochondral fractures. We report our experience with 15 anterior cruciate ligament injuries and 38 meniscus injuries treated between 1996 and 2001. The treatment of anterior cruciate ligament injuries is determined by Tanner's maturity criteria. In the three cases of Stage II injuries, surgery was delayed for up to 24 months in the 12 older patients, an immediate reconstruction was done using hamstring tendons in the three youngest patients, and patellar tendon treatment was done in the remaining cases. We had only one complication caused by the fracturing of the bone plug. The most frequent meniscus injuries were the traumatic tears (23 cases), 80% of which were peripheral and longitudinal. Whenever possible, the entire meniscus (suture in 4 cases) or the greater part of it (economic resection in 19 cases) should be conserved. Despite the satisfactory results, the average followup of the meniscal series (26.1 months) is too short a period to evaluate thoroughly the deterioration of the joint after a meniscectomy.
- Published
- 2005
- Full Text
- View/download PDF
40. Pathologic fractures in children.
- Author
-
Ortiz EJ, Isler MH, Navia JE, and Canosa R
- Subjects
- Adolescent, Bone Cysts complications, Bone Neoplasms complications, Child, Child, Preschool, Female, Fibroma complications, Follow-Up Studies, Fracture Healing, Fractures, Spontaneous etiology, Humans, Male, Osteosarcoma complications, Outcome and Process Assessment, Health Care, Retrospective Studies, Treatment Outcome, Fractures, Spontaneous therapy, Orthopedics methods, Pediatrics methods
- Abstract
Fractures through bone tumors are often difficult to treat. We reviewed our combined experience with this problem in children, as well as the existing literature, to formulate management guidelines. For this study, prospective databases (1987 to 2002) from three referral centers were screened for pathologic fractures occurring under the age of 14 years. One hundred five patients presented with fracture through unicameral bone cyst, nonossifying fibroma, fibrous dysplasia, aneurysmal bone cyst and osteosarcoma. Seventeen patients were excluded. The most common primary locations were the proximal humerus and proximal femur. Pathologic fracture through nonossifying fibroma had the best outcome; union occurred with nonsurgical treatment in all cases. Unicameral bone cyst required surgical treatment to avoid persistence of the cyst and refracture. However fracture healing was predictable without surgical treatment. Proximal femoral lesions tended to heal in malunion if not fixed surgically. Aneurysmal bone cyst required surgical treatment for the lesion to heal and to allow the fracture to heal as well. Percutaneous sclerotherapy may be the treatment of choice for many of these lesions. Fibrous dysplasia allows fracture healing with nonoperative therapy. Progressive deformity requires followup and surgical correction. Malignant lesions presenting a pathologic fracture are best managed by initial nonoperative therapy during investigation and neoadjuvant therapy when possible, followed by definitive treatment.
- Published
- 2005
- Full Text
- View/download PDF
41. The use of cement in osteoarticular allografts for proximal humeral bone tumors.
- Author
-
DeGroot H, Donati D, Di Liddo M, Gozzi E, and Mercuri M
- Subjects
- Adolescent, Adult, Bone Neoplasms complications, Female, Fractures, Spontaneous etiology, Fractures, Spontaneous surgery, Humans, Male, Middle Aged, Postoperative Complications epidemiology, Retrospective Studies, Bone Cements, Bone Neoplasms surgery, Bone Transplantation, Humerus surgery, Shoulder Joint surgery
- Abstract
In a proximal humerus resection for a bone tumor, the use of an osteoarticular allograft is considered the best restoration of shoulder function. We retrospectively reviewed the outcomes of 31 patients who had an intraarticular resection of the proximal humerus for a bone tumor. Twenty-three of the allografts were filled with cement. The average followup was 5.3 years. Of the 31 patients with more than 24 months followup, seven had revision surgery or removal of the allograft. Kaplan-Meier analysis showed that the probability of survival of the reconstruction was 78% at 5 years. Fracture was the main complication in 11 patients (37%) of whom seven were in the noncemented group. Four of these patients had successful surgery for conversion to an allograft-prosthetic composite, whereas one patient had a new allograft. Allografts that were filled with cement had four fractures (18%); three were subchondral fractures discovered by routine CT scans. None of these patients had pain or needed revision surgery. Osteochondral allograft in proximal humerus replacement is a reliable reconstructive technique if the allograft is augmented by filling the intramedullary space with cement. Moreover, cement augmented allografts are less expensive and technically easier than allograft-prosthetic composites.
- Published
- 2004
- Full Text
- View/download PDF
42. Complications and results of arthroplasty for salvage of failed treatment of malignant pathologic fractures of the hip.
- Author
-
Jacofsky DJ, Haidukewych GJ, Zhang H, and Sim FH
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Salvage Therapy, Treatment Failure, Arthroplasty, Replacement, Hip adverse effects, Femoral Neoplasms complications, Fractures, Spontaneous etiology, Fractures, Spontaneous surgery, Hip Fractures surgery
- Abstract
The purpose of this study was to evaluate the results and complications of hip arthroplasty done for salvage of failed treatment of pathologic proximal femoral fractures secondary to malignancy. Between 1980 and 2000, 42 patients with a mean age of 63 years were treated with hip arthroplasty to salvage failed treatment of a pathologic proximal femoral fracture. Total hip arthroplasty was done in 16 patients (3 uncemented, 2 hybrid, 11 cemented), and bipolar hemiarthroplasty in 26 (2 uncemented, 24 cemented). A modular, proximal femoral replacement construct was used in 15 patients. Patients were followed a mean of 5.8 years (range, 15 days-20 years). Four hips required reoperation, all for deep infection. Harris Hip score improved from an average of 42 points (range, 17-76 points) preoperatively to an average of 83 points (range, 52-100 points) postoperatively. Most recent radiographs showed femoral component loosening in only one patient. Implant survivorship free of revision for any reason at 5 years was 90% (range, 65-96%) and free of revision for aseptic failure or radiographic failure was 97% (range, 64-99%). Hip arthroplasty is an effective treatment for salvage of failed treatment of pathologic proximal femoral fractures. Modular proximal femoral replacements were often required. The most concerning complication was deep prosthetic infection, which occurred in nearly 10% of this patient population, and in 21% of patients with prior irradiation.
- Published
- 2004
- Full Text
- View/download PDF
43. Clinical relevance of calcaneal bone cysts: a study of 50 cysts in 47 patients.
- Author
-
Pogoda P, Priemel M, Linhart W, Stork A, Adam G, Windolf J, Rueger JM, and Amling M
- Subjects
- Adolescent, Adult, Child, Female, Fractures, Spontaneous etiology, Humans, Male, Middle Aged, Bone Cysts complications, Bone Cysts diagnosis, Bone Cysts therapy, Calcaneus injuries
- Abstract
The clinical relevance and nature of calcaneal cysts is controversial. The risk of pathologic fracture is undefined and diagnostic criteria to differentiate between cysts in patients who can be treated nonoperatively and patients who require surgical intervention are not available. To address these questions, 50 calcaneal bone cysts in 47 patients were evaluated. The majority of cysts (40 of 50) were asymptomatic and were treated nonoperatively. Cysts reaching a critical size, defined as 100% intracalcaneal cross section in the coronary plane and at least 30% in the sagittal plane, are at risk for becoming symptomatic and at risk for fracture. Fracture is a significant complication and occurred in four of 47 patients, three of whom were treated by open reduction internal fixation and bone grafting. In addition, six patients with symptomatic critical size cysts without apparent fracture were treated by curettage and subsequent autogenous bone grafting or calcium-phosphate cement filling, and there were no recurrences. We report one of the largest series of cysts in the calcaneus. The results suggest that calcaneal cysts are clinically relevant because of the potential risk of fracture and that size is a significant factor in terms of the treatment of the cyst.
- Published
- 2004
- Full Text
- View/download PDF
44. Insufficiency fracture of the body of the calcaneus in elderly patients with osteoporosis: a report of two cases.
- Author
-
Ito K, Hori K, Terashima Y, Sekine M, and Kura H
- Subjects
- Aged, Densitometry, Female, Fracture Healing physiology, Fractures, Spontaneous etiology, Fractures, Spontaneous rehabilitation, Humans, Immobilization, Injury Severity Score, Magnetic Resonance Imaging methods, Osteoporosis, Postmenopausal diagnostic imaging, Pain Measurement, Radionuclide Imaging methods, Risk Assessment, Tomography, X-Ray Computed, Calcaneus injuries, Fractures, Spontaneous diagnosis, Osteoporosis, Postmenopausal complications
- Abstract
Two cases of insufficiency fracture of the body of the calcaneus are presented to show its clinical presentation and diagnosis. It often is overlooked as a cause of pain in the ankle region. Both patients were elderly women with pain developing at the lateral aspect of the hindfoot in the absence of significant trauma. Physical examination was significant for marked tenderness at the superolateral aspect of the calcaneus. These clinical features suggested the diagnosis, which was confirmed by radionuclide bone scan and magnetic resonance imaging. Magnetic resonance imaging was the diagnostic tool in both cases, after abnormal bone scans and normal plain radiographs. Radiologic alterations were not seen for up to 2 months after the onset of pain. Treatment consisted of rest and protected weightbearing for 8 weeks, with complete resolution of symptoms in both patients. An insufficiency fracture of the body of the calcaneus should be considered in a differential diagnosis of elderly patients with osteoporosis with spontaneous pain in the ankle region.
- Published
- 2004
- Full Text
- View/download PDF
45. Metastatic burst fracture risk prediction using biomechanically based equations.
- Author
-
Roth SE, Mousavi P, Finkelstein J, Chow E, Kreder H, and Whyne CM
- Subjects
- Adult, Aged, Biomechanical Phenomena, Bone Density, Cohort Studies, Female, Fractures, Spontaneous epidemiology, Fractures, Spontaneous pathology, Humans, Incidence, Male, Middle Aged, Predictive Value of Tests, Probability, Retrospective Studies, Risk Assessment, Spinal Fractures pathology, Spinal Neoplasms pathology, Stress, Mechanical, Tomography, X-Ray Computed, Fractures, Spontaneous etiology, Lumbar Vertebrae, Spinal Fractures epidemiology, Spinal Fractures etiology, Spinal Neoplasms secondary, Thoracic Vertebrae
- Abstract
Clinical guidelines are a useful adjunct to select patients with spinal metastases for prophylactic intervention. The objective of this study is to determine the ability of biomechanically based models to accurately predict metastatic burst fracture risk. Ninety-two vertebrae with osteolytic spinal metastases were examined retrospectively. Vertebrae were categorized as burst fractured, wedge fractured, or intact and analyzed using three predictive models: vertebral bulge (maximum radial displacement under load), vertebral axial displacement (maximum axial displacement under load), and a volumetric estimate of tumor size. The load-bearing capacity parameter (tumor volume, bone mineral density, disc quality, pedicle involvement) was determined from computed tomography while the load-bearing requirement parameter (pressure load, loading rate) was determined using computed tomography and patient records (retrieved for 37 patients [52%]). Fracture prediction was optimized using the vertebral bulge model considering only load-bearing capacity with a specificity, sensitivity, and confidence interval of 1 to yield a clear threshold for burst fracture risk. Fracture prediction in the other two models, vertebral axial displacement considering only load-bearing capacity and tumor size, also was strong with receiver-operator curve values of 0.992 and 0.988, respectively. The predictive power of these models can provide useful clinical information for prophylactic decision-making.
- Published
- 2004
- Full Text
- View/download PDF
46. Critical evaluation of Mirels' rating system for impending pathologic fractures.
- Author
-
Damron TA, Morgan H, Prakash D, Grant W, Aronowitz J, and Heiner J
- Subjects
- Adult, Aged, Breast Neoplasms pathology, Female, Femoral Neoplasms complications, Fractures, Spontaneous etiology, Humans, Lung Neoplasms pathology, Male, Middle Aged, Reproducibility of Results, Sensitivity and Specificity, Femoral Neoplasms secondary, Fractures, Spontaneous classification
- Abstract
This project examined the hypothesis that Mirels' rating system for impending pathologic fractures is reproducible, valid, and applicable across various experience levels and training backgrounds. Twelve true clinical histories and corresponding radiographs for patients with femoral metastatic lesions were reviewed by 53 participants from five experience levels: orthopaedic residents, musculoskeletal radiologists, orthopaedic attendings, fellowship-trained practicing orthopaedic oncologists, and radiation or medical oncologists. Each examiner provided individual and total Mirels' scores and independent determination of impending fracture using clinical judgment. A subset of seven histories without prophylactic fixation provided a natural history group. There was highly significant agreement across experience categories for overall Kappa and for the concordance for individual and overall scores. Kappa analysis showed good agreement for site, moderate agreement for type, and fair agreement for size and pain. There was no significant difference in overall scores across experience levels. The pooled odds ratio favored Mirels rating system over clinical judgment regardless of experience level. Overall sensitivity was 91% and specificity was 35%. Mirels' system seems to be reproducible, valid, and more sensitive than clinical judgment across experience levels. However, although the system is a valuable screening tool, more specific parameters are needed.
- Published
- 2003
- Full Text
- View/download PDF
47. Pathologic fracture as a complication in the treatment of Ewing's sarcoma.
- Author
-
Fuchs B, Valenzuela RG, and Sim FH
- Subjects
- Adolescent, Adult, Amputation, Surgical, Bone Neoplasms diagnosis, Bone Neoplasms mortality, Child, Child, Preschool, Combined Modality Therapy, Disease-Free Survival, Female, Follow-Up Studies, Fracture Fixation, Internal, Fracture Healing, Fractures, Spontaneous epidemiology, Fractures, Spontaneous therapy, Humans, Immobilization, Male, Neoplasm Staging, Prognosis, Proportional Hazards Models, Risk Factors, Sarcoma, Ewing diagnosis, Sarcoma, Ewing mortality, Time Factors, Treatment Outcome, Bone Neoplasms complications, Bone Neoplasms therapy, Fractures, Spontaneous etiology, Sarcoma, Ewing complications, Sarcoma, Ewing therapy
- Abstract
The purpose of the current study was to define the outcome of patients with Ewing's sarcoma who sustained a fracture either at initial presentation or subsequent to multimodal treatment, and to identify parameters that may influence the treatment of these patients. The age of the 21 males and 14 females who sustained a fracture during the treatment for Ewing's sarcoma averaged 15 years (range, 4-30 years) at diagnosis. Fourteen patients presented with a pathologic fracture, whereas 21 patients had a fracture develop subsequent to the initial treatment at a mean of 4 years (range, 1-19 years). The femur was the most common location (50%). At a mean followup of 10 years (range, 1-33 years), 21 of 35 patients (60%) were alive and free of disease. There was no local recurrence, but there was one postradiation sarcoma associated with the fracture. Comparing the followup of patients who sustained the fracture at presentation with the followup of patients who subsequently had a fracture, no statistically significant difference was found (117 months versus 124 months). Overall, pathologic fracture in association with Ewing's sarcoma does not seem to be a negative prognostic parameter with respect to survival in this series. Therefore, a fracture at presentation may not mandate amputation. However, it occurs frequently subsequent to initial multimodal treatment because of delayed fracture healing. Because conservative or minimal osteosynthesis have high failure rates, more aggressive resection and reconstruction have to be considered carefully.
- Published
- 2003
- Full Text
- View/download PDF
48. Vertebroplasty and kyphoplasty for osteolytic vertebral collapse.
- Author
-
Lieberman I and Reinhardt MK
- Subjects
- Fractures, Spontaneous etiology, Humans, Injections, Osteolysis etiology, Osteoporosis complications, Polymethyl Methacrylate therapeutic use, Spinal Fractures etiology, Spinal Fractures physiopathology, Bone Cements therapeutic use, Fracture Fixation, Internal methods, Fractures, Spontaneous surgery, Multiple Myeloma complications, Polymethyl Methacrylate administration & dosage, Spinal Fractures surgery
- Abstract
As many as 70% of patients with cancer and multiple myeloma initially present with osteolytic involvement of the spine. These vertebral fractures are associated with significant morbidity and mortality and represent a tremendous personal and societal burden. Traditional medical and surgical options often are inadequate or too invasive for this population debilitated by cancer. Vertebroplasty involves the injection of polymethylmethaerylate to strengthen a vertebra. This minimally invasive method, which has been adopted by practitioners during the past decade to treat symptomatic osteoporotic compression fractures is reported to provide quick pain relief in 90% of patients, with only infrequent, mostly minor, complications. In patients with osteolytic fractures, vertebroplasty is associated with an increased rate of cement leak and less predictable pain relief. Kyphoplasty is an extension of vertebroplasty that uses an inflatable bone tamp to restore the vertebral body toward its original height while creating a cavity to be filled with bone cement. Preliminary data indicate that kyphoplasty is a safe procedure associated with a lower risk of cement leak, restoration of vertebral body height, and sagittal spinal alignment. In patients with osteolytic fractures secondary to multiple myeloma, kyphoplasty yields quick pain relief, and is associated with a statistically significant improvement in generic health outcome measures.
- Published
- 2003
- Full Text
- View/download PDF
49. Prostate cancer and bone metastases: medical treatment.
- Author
-
Clark PE and Torti FM
- Subjects
- Antineoplastic Agents, Hormonal therapeutic use, Bone Density drug effects, Bone Neoplasms physiopathology, Diphosphonates pharmacology, Diphosphonates therapeutic use, Disease Progression, Estramustine therapeutic use, Fractures, Spontaneous etiology, Fractures, Spontaneous physiopathology, Gonadotropin-Releasing Hormone analogs & derivatives, Humans, Hyperparathyroidism metabolism, Male, Prostatic Neoplasms drug therapy, Bone Neoplasms drug therapy, Bone Neoplasms secondary, Prostatic Neoplasms pathology
- Abstract
Prostate cancer is the most common malignancy in men in the United States. With the long natural history of the disease, management of skeletal morbidity related to advanced prostate cancer becomes a major public health issue. The standard of care in advanced prostate cancer is androgen deprivation therapy. This may accelerate the development of osteoporosis and further exacerbate the risks of having adverse skeletal-related events develop. Recently, the use of bisphosphonates in men who have not responded to androgen deprivation therapy has been shown to reduce the incidence of skeletal-related events with time. Questions remain as to whether bisphosphonates should be broadly applied to earlier stages of the disease or tailored to men at higher risk of having bone-related morbidity. Work is ongoing to improve other approaches to the medical treatment of bone metastases in patients with advanced prostate cancer including the use of radiopharmaceuticals and combined chemotherapy.
- Published
- 2003
- Full Text
- View/download PDF
50. Metastatic disease in long bones: A proposed scoring system for diagnosing impending pathologic fractures. 1989.
- Author
-
Mirels H
- Subjects
- Bone Neoplasms classification, Bone Neoplasms complications, Fractures, Spontaneous diagnosis, Fractures, Spontaneous etiology, History, 20th Century, Humans, Orthopedics history, Risk Factors, South Africa, United States, Bone Neoplasms history, Fractures, Spontaneous history
- Abstract
A weighted scoring system is proposed to quantify the risk of sustaining a pathologic fracture through a metastatic lesion in a long bone. This system objectively analyzes and combines four roentgenographic and clinical risk factors into a single score. Retrospective analysis of metastatic long bone lesions was completed in 78 lesions that had been irradiated without prophylactic surgical fixation. Clinical data and roentgenograms were scored prior to irradiation by independent observers. The outcome identified 51 lesions that did not fracture during the subsequent six months and 27 lesions that fractured within six months. A mean score of 7 was found in the nonfracture group, whereas the fracture group had a mean score of 10. The percentage risk of a lesion sustaining a pathologic fracture could be predicted for any given score. As the score increased above 7, so did the percentage risk of fracture. It is suggested that all metastatic lesions in long bones be evaluated prior to irradiation. Lesions with scores of 7 or lower can be safely irradiated without risk of fracture, while lesions with scores of 8 or higher require prophylactic internal fixation prior to irradiation.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.